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A B S T R A C T
Background
The use of conventional cardiotocographic (CTG) monitoring of fetal well-being during labour is associated with an increased caesarean
section rate, compared with intermittent auscultation of the fetal heart rate, resulting in a reduction in neonatal seizures, although
no differences in other neonatal outcomes. To improve the sensitivity of this test and therefore reduce the number of caesarean
sections performed for nonreassuring fetal status, several additional measures of evaluating fetal well-being have been considered. These
have demonstrated some effect on reducing caesarean section rates, for example, fetal scalp blood sampling for pH estimation/lactate
measurement. The adaptation of pulse oximetry for use in the unborn fetus could potentially contribute to improved evaluation during
labour and therefore lead to a reduction in caesarean sections for nonreassuring fetal status, without any change in neonatal outcomes.
Objectives
To compare the effectiveness and safety of fetal intrapartum pulse oximetry with other surveillance techniques.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (31May 2014), contacted experts in the field and searched
reference lists of retrieved studies. In previous versions of this review, we performed additional searches of MEDLINE, Embase and
Current Contents. These searches were discontinued for this review update, as they consistently failed to identify any trials that were
not shown in the Cochrane Pregnancy and Childbirth Group’s Trials Register.
Selection criteria
All published and unpublished randomised controlled trials that compared maternal and fetal outcomes when fetal pulse oximetry
was used in labour, (i) with or without concurrent use of conventional fetal surveillance, that is, cardiotocography (CTG), compared
with using CTG alone or (ii) with or without concurrent use of both CTG and other method(s) of fetal surveillance, such as fetal
electrocardiography (ECG) plus CTG.
Data collection and analysis
At least two independent review authors performed data extraction. We sought additional information from the investigators of three
of the reported trials.
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Main results
We included seven published trials: six comparing fetal pulse oximetry and CTG with CTG alone (or when fetal pulse oximetry
values were blinded) and one comparing fetal pulse oximetry plus CTG with fetal ECG plus CTG. The published trials, with some
unpublished data, were at high risk of bias in terms of the impractical nature of blinding participants and clinicians, as well as high risk
or unclear risk of bias for outcome assessor for all but one report. Selection bias, attrition bias, reporting bias and other sources of bias
were of low or unclear risk. The trials reported on a total of 8013 pregnancies. Differing entry criteria necessitated separate analyses,
rather than meta-analysis of all trials.
Systematic review of four trials from 34 weeks not requiring fetal blood sampling (FBS) prior to study entry showed no evidence of
differences in the overall caesarean section rate between those monitored with fetal oximetry and those not monitored with fetal pulse
oximetry or for whom the fetal pulse oximetry results were masked (average risk ratio (RR) 0.99 using random-effects, 95% confidence
intervals (CI) 0.86 to 1.13, n = 4008, I² = 45%). There was evidence of a higher risk of caesarean section in the group with fetal
oximetry plus CTG than in the group with fetal ECG plus CTG (one study, n = 180, RR 1.56, 95% CI 1.06 to 2.29). Neonatal
seizures and neonatal encephalopathy were rare in both groups. No studies reported details of long-term disability.
There was evidence of a decrease in caesarean section for nonreassuring fetal status in the fetal pulse oximetry plus CTG group compared
to the CTG group, gestation from 34 weeks (average RR (random-effects) 0.65, 95% CI 0.46 to 0.90, n = 4008, I² = 63%). There
was no evidence of differences between groups in caesarean section for dystocia, although the overall incidence rates varied between
the trials.
Authors’ conclusions
The addition of fetal pulse oximetry does not reduce overall caesarean section rates. One study found a higher caesarean section rate in
the group monitored with fetal pulse oximetry plus CTG, compared with fetal ECG plus CTG. The data provide limited support for
the use of fetal pulse oximetry when used in the presence of a nonreassuring CTG, to reduce caesarean section for nonreassuring fetal
status. A better method than pulse oximetry is required to enhance the overall evaluation of fetal well-being in labour.
P L A I N L A N G U A G E S U M M A R Y
Fetal pulse oximetry for fetal assessment in labour
Using fetal pulse oximetry to assess the baby’s well-being during labour does not change overall caesarean section rates.
During labour, the well-being of the baby can be assessed intermittently using a Pinard stethoscope or hand-held monitor to listen
to the heart rate, or continuously using cardiotocography (CTG), sometimes called electronic fetal monitoring (EFM). There are also
additional tests that can be used if the baby is thought to be getting short of oxygen, like testing the baby’s blood in a sample taken
from the baby’s head or bottom, or through the recording of the electrical activity of the heart using an electrocardiogram (ECG). Fetal
pulse oximetry measures how much oxygen the baby’s blood is carrying. It uses a probe that sits on the baby’s head whilst in the uterus
and vagina during labour. The probe is said not to interfere with the woman’s mobility during labour. This review looked at fetal pulse
oximetry and found trials that used it in conjunction with a CTG. We compared the outcomes for this combined oximetry and CTG,
with outcomes where only the CTG had been used, or a combination of CTG and fetal ECG had been used.
The review identified seven trials involving 8013 women. Fetal pulse oximetry plus CTG showed no difference in caesarean section
rates overall, nor any difference in the mother’s or newborn’s health, compared with CTG alone. If there was concern about the baby’s
well-being before the fetal pulse oximetry probe was placed, the use of fetal pulse oximetry reduced caesarean sections performed for
the baby’s well-being. The one trial of oximetry with CTG compared with CTG and fetal ECG showed an increase in the caesarean
rate in the oximetry group. In two of the trials, the company making the fetal pulse oximetry machines provided some funding. A
better method than fetal pulse oximetry is needed for checking on the well-being of the baby during labour.
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B A C K G R O U N D
Description of the condition
Cardiotocography (CTG) was introduced in the 1960s with the
aim of improving neonatal outcomes by improving intrapartum
fetal surveillance. The uterine contractions and the fetal heart
rate, variability, decelerations and accelerations influence the way
these patterns are classified. Terms in use include normal, reassur-
ing, nonreassuring, indeterminate, suspicious, abnormal, patho-
logical and preterminal (ACOG 2001; FIGO 1987; NICE 2007;
RANZCOG 2014). In this review, we refer to the terms reassur-
ing, nonreassuring or abnormal. Reassuring patterns require no
specific action. Nonreassuring patterns occur in about 15% to
19% of labours monitored by CTG (East 2006; Umstad 1993)
and may prompt clinical actions ranging from simple manoeu-
vres, such as a change of maternal position, through to expedited
birth of the baby (vacuum, forceps, caesarean section). Abnormal
patterns usually prompt expedited birth with the aim of prevent-
ing or minimising hypoxia in the fetus. The positive predictive
value of CTG for adverse outcome is low and the negative pre-
dictive value high (Nonnenmacher 2010), although this is im-
proving with computerised interpretation of CTGs (Costa 2010).
Thus, while a normal CTG usually indicates reassuring fetal sta-
tus, a nonreassuring or abnormal CTG does not necessarily equate
with ’fetal distress’. These features, combined with marked inter-
observer variation in CTG interpretation by midwives (Devane
2005) and doctors (Palomaki 2006), result in variable but inap-
propriately high operative birth rates for nonreassuring fetal sta-
tus in many hospitals. Electronic fetal monitoring rapidly gained
widespread acceptance for monitoring the fetal heart rate during
labour, but it was not until the 1970s that randomised controlled
trials were conducted to assess the benefits of this technology. A
Cochrane systematic review found that the use of electronic mon-
itoring increased the odds of having a caesarean section, compared
to intermittent auscultation of the fetal heart (Alfirevic 2013). De-
spite these shortcomings, cardiotocography remains a widely used
means of assessing fetal well-being during labour. One conclusion
of the systematic review of CTG monitoring was to consider how
best to convey the uncertainty of the benefits of such monitoring
to enable women to make an informed choice, while not compro-
mising labour normality (Alfirevic 2013). The National Institute
for Health and Clinical Excellence (NICE 2007) suggested that,
as for all aspects of care, the woman herself should be involved in
decision-making for choice of fetal monitoring, with adequate ac-
cess to evidence-based information; and recommended that elec-
tronic monitoring be offered where there is an increased risk of
perinatal death, neonatal encephalopathy or cerebral palsy, and
during labours induced or augmented by oxytocin.
Once a nonreassuring fetal heart rate pattern has been identified, a
number of additional assessments of fetal well-being may be con-
sidered. These do not replace the CTG, but are usually used as
complementary to it, either intermittently or continuously. One
example is fetal scalp blood sampling for pH or lactate analysis. A
low pH (for example, less than 7.20) or a high lactate (for example
greater than 4.8 mmol/L) may be considered abnormal (Kruger
1999). The addition of fetal scalp blood sampling to standard elec-
tronicmonitoring reduces the odds for caesarean section, although
the odds are not significantly different compared to intermittent
auscultation of the fetal heart (Alfirevic 2013). Another example is
fetal electrocardiogram (ECG), which measures fetal ST interval
and the changes in the T/QRS ratio. An elevation of the ST seg-
ment and the ratio between the T wave and QRS amplitudes (T/
QRS), identifies fetal anaerobic myocardial metabolism (Ros n
2004). A Cochrane systematic review of the addition of fetal elec-
trocardiogram monitoring reported no evidence of a difference in
overall caesarean section rate when compared to electronic moni-
toring only (Neilson 2013). Dokus 2013 considered the potential
impact of the declining clinical use of fetal ECG and fetal pulse
oximetry (described below), noting that the overall caesarean sec-
tion rate increased when either fetal ECG or fetal pulse oximetry
were no longer available for use (total n = 13,413). Cochrane sys-
tematic reviews of vibroacoustic stimulation (VAS) or fetal scalp
blood sampling for lactate measurement as additional fetal assess-
ments in labour were unable to identify randomised controlled tri-
als that compared these interventions with no intervention (East
2010; East 2013).
Description of the intervention
Fetal pulse oximetry aims to improve the accuracy of the evalua-
tion of fetal well-beingduring labour (Colditz 1999;Coldtiz 2013;
East 2007a). It is generally reserved for use when a nonreassuring
CTG has been recorded, to assist in identifying those fetuses that
may benefit from further intervention (East 2002; East 2008) and
as an adjunct to, rather than replacement of, the CTG monitor.
This method has two potential advantages over conventional fetal
heart rate monitoring: (i) it directly measures the proportion of
haemoglobin that is carrying oxygen: thus, oxygenation, the pri-
mary variable underlying the tissue damaging effects of hypoxia/
ischaemia is being monitored; and (ii) it relies on an established,
safe, noninvasive, widely-used technology found in every modern
intensive care unit and operating theatre. Inaccurate oxygen sat-
uration readings can occur with conditions that decrease arterial
blood perfusion, for instance, they can occur with venous pulsa-
tions, excessive movement, intravenous pigmented dyes, and ab-
normal haemoglobin (Chan 2013). A variety of fetal pulse oxime-
try sensors has been studied. These are placed during a vaginal ex-
amination to attach to the top of the fetal head by suction (Arikan
2000) or clip (Knitza 2004), lie against the fetal temple or cheek
(Mallinckrodt 2000; Nellcor 2004), or to lie along the fetal back
(Prothia 2014). The sensor remains in situ and fetal pulse oxime-
try values are recorded for approximately 81% of the monitoring
time (East 1997). Women have rated their experience with fetal
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oximetry during observational studies. One survey included ques-
tions about the woman’s perceived level of comfort during sensor
placement, mobility with the sensor in place and ongoing comfort
with the sensor in place: these factors were all rated favourably by
the women (East 1996). Arikan 1998 reported that the majority
of women did not consider that a fetal oximetry sensor restricted
their movement during labour.
How the intervention might work
Results of animal and human research suggest that when using
sensors calibrated for the fetal environment, fetal oximetry values
greater than or equal to 30% are considered reassuring, even when
the CTG is nonreassuring, while values less than 30% warrant
consideration of interventions, ranging from maternal position
change, through to urgent birth via caesarean section (Kuhnert
1998; Nijland 1995; Seelbach-Gobel 1999). A prospective, ob-
servational cohort study investigating relationship between oxy-
gen saturation using pulse oximetry and umbilical cord arterial
pH values in healthy newborns during the first 15 minutes of life
found a significant correlation between both preductal and post-
ductal oxygen saturation levels and umbilical arterial blood pH
values (Uslu 2012). A prospective observational study found a low
pulse oximetry oxygen saturation < 30% for at least 10 minutes
correlates highly with fetal acidosis in cases of nonreassuring fetal
heart rate (Nonnenmacher 2010). A novel fetal phantom based
on actual fetal parameters showed that the wireless oximeter was
capable of identifying 4% and 2% changes in diameter between
the diastolic and systolic point in arteries of over 0.2 and 0.4
mm inner diameter, respectively (Stubán 2009). One manufac-
turer recommends this technology for singleton pregnancies only
(Nellcor 2004). Consideration for monitoring multiple pregnan-
cies by monitoring the first fetus during labour, then the second
or subsequent fetuses following birth of the preceding fetus may
be possible.
Why it is important to do this review
The value of any fetal monitoring system during labour, including
the CTG or any additional surveillance, is usually expressed by its
ability to predict which fetuses are hypoxic or acidotic. Measures
of this may include umbilical cord blood gases (including base
excess values less than or equal to 12 mmol/L and pH values less
than 7.00 (Sehdev 1997), or less than 7.10 (Arikan 2000) or lac-
tate values > 6.1 mmol/L (White 2010); or clinical outcomes in-
cluding Apgar scores (an assessment of neonatal condition shortly
after birth, usually at one and five minutes: Apgar scores of less
than seven at five minutes or later are nonspecific but may be as-
sociated with hypoxia (MacLennan 1999; Sehdev 1997)); or ab-
normal neurological status of the baby, possibly caused by lack of
oxygen or blood supply (hypoxic-ischaemic encephalopathy), or
both. Other outcomes of interest may include fetal/maternal in-
fections, for example of the membranes (chorioamnionitis), or the
uterine lining (endometritis). Interventions resulting from such
tests are also important. For example, it is important to note not
only overall modes of birth following different forms of monitor-
ing, but also specific interventions, such as operative birth (vac-
uum, forceps and caesarean section) for the indication of nonre-
assuring fetal status, since nonreassuring fetal status is what the
monitoring is intended to discern. In the longer term, such inter-
ventions may also impact on future pregnancies. For example, the
likelihood of a successful vaginal birth after caesarean (VBAC) in
a subsequent pregnancy is improved for women whose previous
caesarean was performed for the indication of nonreassuring fe-
tal status, compared with those where the previous caesarean was
performed for dystocia (Grinstead 2004; Shipp 2000). Successful
VBAC in a subsequent pregnancy will also have economic bene-
fits, with vaginal births costing the health system considerably less
than caesarean sections (Henderson 2001; Petrou 2002).
This review was undertaken to evaluate the clinical effectiveness
and safety of fetal pulse oximetry to assess fetal well-being in labour.
O B J E C T I V E S
To compare the effectiveness and safety of fetal intrapartum pulse
oximetry with conventional fetal surveillance techniques, using
the results of randomised controlled trials.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All published and unpublished individual- or cluster-randomised
and quasi-randomised trials with reported data that comparedma-
ternal and fetal/neonatal/infant outcomes when fetal pulse oxime-
try was used in labour, with or without concurrent use of conven-
tional fetal surveillance, compared with the use of conventional
fetal surveillance techniques alone.
Cross-over studies are unlikely to be appropriate for testing this
intervention and therefore would be excluded if identified. We
also excluded studies that are only available in abstract form.
Types of participants
Women in labour with a live baby where fetal monitoring is clin-
ically indicated.
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Types of interventions
Use of fetal pulse oximetry compared with not using fetal pulse
oximetry, with or without concurrent use of conventional fetal
monitoring (fetal heart rate monitoring by intermittent ausculta-
tion, intermittent/continuous cardiotocography, fetal electrocar-
diography [added in this review update], or fetal blood sampling
(FBS) for blood gas analysis).
Types of outcome measures
Primary outcomes
(1) Caesarean section
(2) Hypoxic-ischaemic encephalopathy
(3) Neonatal seizures
(4) Long-term neurodevelopmental outcome
Secondary outcomes
Maternal
(5) Caesarean section for nonreassuring fetal status
(6) Caesarean section for dystocia (added since the protocol and
original review were first published)
(7) Overall operative birth (caesarean section, forceps, vacuum
extraction) for all indications
(8) Overall operative birth (caesarean section, forceps, vacuum
extraction) for nonreassuring fetal status
(9) Use of intrapartum antibiotics
(10) Overall antibiotic use
(11) Intrapartum haemorrhage
(12) Postpartum haemorrhage
(13) Chorioamnionitis
(14) Endometritis (added since the protocol was first published)
(15) Uterine rupture
(16) Length of hospital stay
(17) Satisfaction with labour
(18) Satisfaction with fetal monitoring in labour
(19) Death
Fetal/neonatal
(20) Skin trauma
(21) Apgar scores less than four at five minutes
(22) Apgar scores less than seven at five minutes
(23) Umbilical arterial pH less than 7.10
(24) Umbilical arterial base excess less than -12
(25) Admission to neonatal intensive care unit
(26) Length of hospital stay
(27) Death
(28) Death, hypoxic-ischaemic encephalopathy, or both
(29) Death, seizures, or both
(30) Death, long-term neurodevelopmental problem, or both
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by the Cochrane Pregnancy and Childbirth Group.
Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group’s Tri-
als Register by contacting the Trials Search Co-ordinator (31 May
2014).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of Embase;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
Embase, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
In previous editions of this review, we searched MEDLINE,
Embase and Current Contents. The Cochrane Pregnancy and
Childbirth Group’s Trials Register reliably records all trials that
would have been identified in these additional databases. We have
therefore only searched the Cochrane Pregnancy and Childbirth
Group’s Trials Register for this update. See: Appendix 1 for the
search strategy used in previous editions of this review.
Searching other resources
We also sought ongoing and unpublished trials by contacting ex-
perts in the field.
We did not apply any language restrictions.
Data collection and analysis
For the methods used when assessing the trials identified in the
previous version of this review, see East 2007.
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For this update we used the following methods when assessing the
reports identified by the updated search.
The followingmethods section of this review is based on a standard
template used by the Cochrane Pregnancy and Childbirth Group.
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies we identified as a result of the search strategy - all
authors participated in these assessments for the range of studies
identified, with two allocated per study. We resolved any disagree-
ments through discussion. If it had been required, we would have
consulted a third person.
Data extraction and management
Wedesigned a form to extract data. For eligible studies, two review
authors extracted the data using the agreed form - all authors
participated in data extraction for the range of included studies,
with two allocated per study. We resolved discrepancies through
discussion. If required, we planned to consult a third person. We
entered data into Review Manager software (RevMan 2012) and
checked for accuracy.
When information regarding any of the above was unclear, we
attempted to contact authors of the original reports to provide
further details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in theCochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). All authors partic-
ipated in assessment of risk of bias of the range of included studies,
with two allocated per study. We resolved any disagreement by
discussion. Had it been required, we would have involved a third
assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it produced comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that
the lack of blinding would be unlikely to affect results.We assessed
blinding separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we re-included missing data in the analyses
which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
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substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
As per the original protocol, wemade an a prioridecision to exclude
trials where outcome data were unavailable for more than 20% of
participants.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We described for each included study any important concerns we
have about other possible sources of bias.
We assessed whether each study was free of other problems that
could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Handbook (
Higgins 2011). With reference to (1) to (6) above, we assessed
the likely magnitude and direction of the bias and whether we
consider it is likely to impact on the findings. We explored the
impact of the level of bias through undertaking sensitivity analyses
- see Sensitivity analysis. Overall findings from our assessment of
risk of bias in the included studies are provided in Figure 1 and
Figure 2.
Figure 1. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
For continuous data, we used the mean difference with 95% con-
fidence intervals. If necessary, we planned to use the standardised
mean difference to combine trials that measured the same out-
come, but used different methods.
Unit of analysis issues
Cluster-randomised trials
We planned to include cluster-randomised trials identified in the
searches in the analyses along with individually-randomised tri-
als. If cluster-randomised trials are included in future updates, we
will adjust their sample sizes using the methods described in the
Handbook using an estimate of the intracluster correlation co-ef-
ficient (ICC) derived from the trial (if possible), from a similar
trial or from a study of a similar population. If we use ICCs from
other sources, we will report this and conduct sensitivity analyses
to investigate the effect of variation in the ICC. If we identify
both cluster-randomised trials and individually-randomised trials,
we will synthesise the relevant information. We will consider it
reasonable to combine the results from both if there is little het-
erogeneity between the study designs and the interaction between
the effect of intervention and the choice of randomisation unit is
considered to be unlikely.
We will also acknowledged heterogeneity in the randomisation
unit and perform a sensitivity analysis to investigate the effects of
the randomisation unit.
Cross-over trials
It is unlikely that cross-over designs will be a valid study design
for Pregnancy and Childbirth reviews, and so will be excluded if
they are identified in future updates of this review.
Dealing with missing data
For included studies, we noted levels of attrition. We explored
the impact of including studies with high levels of missing data
in the overall assessment of treatment effect by considering using
sensitivity analysis, although this was not ultimately necessary.
For all outcomes, we carried out analyses, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partic-
ipants randomised to each group in the analyses, and all partici-
pants were analysed in the group to which they were allocated, re-
gardless of whether or not they received the allocated intervention.
The denominator for each outcome in each trial was the number
randomised minus any participants whose outcomes were known
to be missing.
We made an a priori decision in the original protocol to exclude
trials where outcome data were unavailable for more than 20% of
participants.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if an I² was greater than 30% and either a Tau² was greater
than zero, or there was a low P value (less than 0.10) in the Chi²
test for heterogeneity.
Assessment of reporting biases
Had there been10ormore studies in themeta-analysis, we planned
to investigate reporting biases (such as publication bias) using fun-
nel plots. In future review updates where 10 or more studies are
included, wewill assess funnel plot asymmetry visually. If asymme-
try is suggested by a visual assessment, we will perform exploratory
analyses to investigate it.
Data synthesis
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2012).We used fixed-effect meta-analysis for com-
bining data where it was reasonable to assume that studies were
estimating the same underlying treatment effect: i.e. where trials
were examining the same intervention, and the trials’ populations
and methods were judged sufficiently similar. If there was clinical
heterogeneity sufficient to expect that the underlying treatment ef-
fects differed between trials, or if substantial statistical heterogene-
ity was detected, we used random-effects meta-analysis to produce
an overall summary, if an average treatment effect across trials was
considered clinically meaningful. The random-effects summary
was treated as the average of the range of possible treatment effects
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and we discussed the clinical implications of treatment effects dif-
fering between trials. If the average treatment effect was not clin-
ically meaningful, we did not combine trials.
Where we used random-effects analyses, the results were presented
as the average treatment effect with 95% confidence intervals, and
the estimates of Tau² and I².
Subgroup analysis and investigation of heterogeneity
If we identified substantial heterogeneity, we investigated it using
subgroup analyses and sensitivity analyses.We considered whether
an overall summary was meaningful, and if it was, used random-
effects analysis to produce it.
We planned to carry out the following subgroup analyses.
1. Fetal heart rate monitoring by:
• intermittent auscultation;
• intermittent cardiotocography;
• continuous cardiotocography and fetal scalp stimulation;
• continuous cardiotocography and fetal ECG analysis (ST
segment);
• continuous cardiotocography and fetal ECG analysis (PR
interval).
2. Fetal scalp blood sampling for blood gas analysis or lactate
measurement (performed after randomisation).
The primary outcomes were used in subgroup analysis.
We planned to assess subgroup differences by interaction tests
available within RevMan (RevMan 2012). We reported the results
of subgroup analyses quoting the Chi² statistic and P value, and
the interaction test I² value.
Sensitivity analysis
We performed sensitivity analyses on the primary outcomes where
we considered that an aspect of the review, such as risk of bias
associated with the quality of some of the included trials, could
have affected the results, in particular where there was a high level
of statistical heterogeneity. This was applied by creating subgroups
based on the different study entry criteria (see Data analysis con-
siderations in the Results section).
R E S U L T S
Description of studies
The search identified seven published randomised controlled trials
(Bloom 2006; Caliskan 2009; East 2006; Garite 2000; Klauser
2005; Kuhnert 2004; Valverde 2011 (the latter added in the 2014
review update)), and two observational studies (Andres 2004;
Golaszewski 1993). The trial by Garite 2000 had also been pub-
lished in a number of forms and sub analyses addressing issues
that were not considered in this review. Similarly, the trials by East
2006, Bloom 2006 and Valverde 2011 had several related pub-
lications (one of which had only been available as a conference
abstract in the 2010 update of this review), some of which were
considered in this review and were added with this update.
We found no unpublished studies.
Trials with nonreassuring fetal status not required
prior to study entry
Bloom 2006 reported a multicentre trial conducted in the USA
(n = 5341), which enrolled nulliparous women with CTG moni-
toring in labour. All participants had a fetal pulse oximetry sensor
placed and were then randomly allocated to the ’open’ arm with
fetal pulse oximetry values displayed or the ’masked’ arm with fetal
pulse oximetry values stored to computer disk and not displayed
to the woman or clinician. These results were analysed separately
from the other studies, as the study population, labouring women
with a CTG, could not be considered in the same manner as those
with a nonreassuring CTG (see below). The report included lim-
ited outcomes for a separate analysis of those with a nonreassuring
CTG prior to study entry.The study reported by Caliskan 2009
enrolled women from 34 weeks’ gestation undergoing induction
of labour by oral misoprostol in Turkey. All participants had miso-
prostol administered and were then randomised to either inter-
mittent fetal pulse oximetry + electronic fetal monitoring, or elec-
tronic fetal monitoring only.
Trials with nonreassuring fetal status required prior
to study entry
The trial published by Garite 2000 was conducted in the United
States of America (USA) and compared caesarean section rates
for nonreassuring fetal status when conventional fetal monitoring
(CTG) was used, versus when fetal pulse oximetry was used in ad-
dition to CTG, with reported data on 1010 cases. An unpublished
report included some pilot data for a total of 1189 cases.
Kuhnert 2004 reported a trial from Germany that compared op-
erative birth and fetal scalp blood sampling for nonreassuring fetal
status in two groups: those with CTG monitoring and those with
fetal pulse oximetry added to the CTG, for a total of 146 cases. Fe-
tal blood sampling (FBS) was required prior to study entry.Whilst
not stated in the report, it is appropriate to consider that if the
scalp pH was nonreassuring, intervention would have been un-
dertaken to correct this or to deliver the baby prior to enrolment
in the study. It can therefore be considered that this represents,
at least in part, a different study population to that of the other
studies.
A single-centre trial from the USA, reported by Klauser 2005, in-
cluded 327 women with gestation from 28 weeks onward. This
study compared caesarean birth for nonreassuring fetal status in
womenwith andwithout fetal pulse oximetry added toCTGmon-
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itoring (Klauser 2005). Interpretation of fetal heart rate monitor-
ing is different in premature babies, compared with term babies.
The report did not allow the reader to distinguish outcomes by
gestational age. It may therefore be appropriate to consider that
this represents a heterogenous population. This would make sub-
sequent combination with other trials inappropriate. We were un-
able to contact the authors to consider analysis by gestation.
An Australian multicentre trial compared operative birth for non-
reassuring fetal status in those with and without fetal pulse oxime-
try added to CTG monitoring (East 2006) on 600 pregnancies.
The trial reported by Bloom 2006 included 2168 women with a
nonreassuringCTGat the time of study entry, of the 5341 enrolled
in the study overall (see above).
Valverde 2011 reported a single-centre trial from Spain that com-
pared operative birth and fetal status in 180 women with non-
reassuring CTG. Women were randomised to either fetal pulse
oximetry plus CTG, or fetal ECG plus CTG.
See Characteristics of included studies table.
Data analysis considerations
The trial by Bloom 2006 involved fetal pulse oximetry and car-
diotocography in both of the study groups, with one group having
the oximetry results displayed for clinical use and the other group
having the oximetry results masked. For the purposes of this meta-
analysis, the ’masked’ group of this trial has been treated in this
review as ’cardiotocography-only’, since the fetal pulse oximetry
values did not influence clinical decisions.
All trials were included, where outcome data were reported, in the
meta-analysis to allow a comprehensive representation of the find-
ings. The use of a summary measure of effect for some combina-
tions of trials was appropriate. However, we did not use a summary
measure of effect for combining all trials, as the appropriateness
of combining studies with differing entry criteria and significant
heterogeneity if separate analyses were not used, remained uncer-
tain. For example, we created subcategories within analyses based
on differing study entry characteristics/requirements: (i) gestation
from34weeks, FBS not required prior to study entry; (ii) gestation
from 36 weeks, FBS prior to study entry; and (iii) gestation from
28 weeks, FBS not required prior to study entry.We then reported
the summary effect for each subgroup, rather than a combined
summary effect for all studies. The subcategories could have been
considered in terms of subgroup analyses, although the different
study entry characteristics were not specified as subgroups a priori
in the original protocol. The findings as presented in subcategories
provide a good measure of clinical realities, although the possibil-
ity of converting these to subgroups may be considered in a future
update of this review.
Inclusion of the trial reported by Valverde 2011 in the 2014 re-
view update prompted careful deliberations related to whether or
not to consider the fetal ECG + CTG group in the same manner
as the CTG-only group used for the remaining studies.The latter
may be a reasonable judgement, given that there is a lack of ev-
idence of effect of adding fetal ECG, on caesarean section rates
(Neilson 2013). Adding the Valverde 2011 findings to the main
analysis of the primary outcome, caesarean section, did not change
the overall direction of the summary effect, although the I2 test
result did increase from 45% to 61%, making it likely that this
heterogeneity was of some importance. In support of treating fetal
ECG separately, withdrawal of fetal pulse oximetry and fetal ECG
from a clinical service, as compared with their use in a research
setting, has been reported to influence a rise in caesarean sections
(Dokus 2013). On the balance of these considerations, a decision
was made to create distinct comparison analyses for fetal ECG,
rather than include the findings from Valverde 2011 in the initial
meta-analysis and then attempt subgroup analysis.
Excluded studies
The two observational studies identified in the search were ex-
cluded (Andres 2004; Golaszewski 1993). See Characteristics of
excluded studies table.
Risk of bias in included studies
In all studies, the fetal oximetry values in the intervention group
were used to guide clinical practice, thus making it impractical
to blind either the participant or the clinician. Two studies (East
2006; Garite 2000) disclosed funding support from the manufac-
turers of the fetal oximetry system used in those studies (high risk).
Only one study (Bloom 2006) reported that outcome assessors
were blinded to group allocation, while the remainder included
sufficient detail to determine that outcome assessment was un-
blinded (East 2006; Garite 2000) and therefore high risk, or did
not specify this information (unclear risk, Caliskan 2009; Klauser
2005; Kuhnert 2004; Valverde 2011). These elements of risk may
suggest the need for caution in over-interpretation of the findings
(Figure 1; Figure 2).
Allocation
Sufficient evidence of random sequence generation and alloca-
tion concealment were provided in the reports by Bloom 2006;
Caliskan 2009; East 2006; and Garite 2000 to rate the risk of bias
as low. The report by Valverde 2011 indicated that sealed, opaque
envelopes were used, but we were unable to confirm whether or
not these were sequentially numbered, thus rating this as unclear
risk of bias. Klauser 2005 and Kuhnert 2004 did not report meth-
ods of randomisation and allocation concealment (unclear risk).
Blinding
In all studies (Bloom 2006; Caliskan 2009; East 2006; Garite
2000; Klauser 2005; Kuhnert 2004; Valverde 2011), blinding of
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the participants or clinicians (performance bias) was not feasible
given that FSpO2 values were used for clinical judgement. The
’masked’ group in the study by Bloom 2006meant that the labour-
ing woman and clinicians were blinded to fetal oximetry values,
although both the women and clinicians were aware of group allo-
cation. The overall risk of bias for these studies was therefore high
for blinding of participants and clinicians.
Outcome assessment (detection bias) of the study reported by
Bloom 2006 was conducted by staff who were unaware of group
allocation, giving it a rating of low risk. All remaining studies
and their outcomes were assessed either unblinded (and therefore
high risk, East 2006; Garite 2000) or blinding was not specified
(and therefore unclear risk, Caliskan 2009; Klauser 2005; Kuhnert
2004; Valverde 2011). A blinded outcome assessor analysis was
performed for a post hoc analysis of partograms in the study by
Garite 2000, conducted to demonstrate progress in labour for all
cases of dystocia (defined) and failed induction of labour (defined).
Incomplete outcome data
All participants acknowledged to have been enrolled in the seven
published studies were accounted for, suggesting that there was a
low risk of bias for outcome data. This could be confirmed for
three studies that had protocols available prior to or during the
trial conduct (Bloom 2006; East 2006; Garite 2000).
Selective reporting
The availability of the trial protocols prior to or during the studies
by Bloom 2006; East 2006; Garite 2000 provided evidence of a
low risk of bias for selective reporting. There is no evidence to
support any concerns of reporting bias in the remainder of the
studies (Caliskan 2009; Klauser 2005; Kuhnert 2004; Valverde
2011).
Other potential sources of bias
Two studies had elements of high risk of other sources of bias, in
so far as the study by Garite 2000 was funded by the manufacturer
of the fetal pulse oximetry used in the trial and funding from
this manufacturer also contributed to overall funds for the trial
reported by East 2006. The large difference in findings from the
study reported byKuhnert 2004 to those reported in the remaining
studies raises the unconfirmed possibility of unclear risk of bias.
There was no evidence to suggest other potential sources of bias
in the remaining studies.
Effects of interventions
We included seven trials involving 8013 participants in this review.
Findings from one new trial, comparing fetal pulse oximetry plus
CTG and fetal ECG plus CTG and involving 180 participants,
was included in this 2014 update of the review (Valverde 2011).
Primary outcomes
Where meta-analysis was possible, findings from five of the seven
trials resulted in no significant differences in the overall caesarean
section rate between those monitored with fetal oximetry and
those not monitored with fetal pulse oximetry or for whom the
fetal pulse oximetry results were masked (four studies, n = 4008,
summary risk ratio (RR) using random-effects, 0.99, 95% confi-
dence intervals (CI) 0.86 to 1.13, I² = 45, Analysis 1.1). A smaller
study for which FBS was required prior to study entry (n = 146)
reported a significant decrease in caesarean section in the fetal
oximetry group, compared with the control group (Analysis 1.1;
Kuhnert 2004). The risk of overall caesarean section rate for those
monitored with fetal pulse oximetry and CTG was higher than
for those monitored with fetal ECG and CTG (one study, n =
180, RR 1.56, 95%CI 1.06 to 2.29, Analysis 5.1; Valverde 2011).
Hypoxic ischaemic encephalopathy was reported in only one case,
in the masked group of the study by Bloom 2006 and generally
not reported at all in other studies (Analysis 1.2). Few studies re-
ported on neonatal seizures, with only one case reported in the
control group of the trial by Garite 2000 and one clinical case in
the intervention group of the trial by East 2006 (Analysis 1.3). No
studies reported details of assessment of long-term disability.
Secondary outcomes: maternal
There was evidence of a significant decrease in caesarean section
for nonreassuring fetal status in the fetal pulse oximetry plus CTG
group compared to the CTG group in two of the four analyses: (i)
gestation from34weekswith FBS not required prior to study entry
(four studies, n = 4008, average RR 0.65 using random-effects,
95% CI 0.46 to 0.90, I² = 63%); and (ii) when FBS was required
prior to study entry (one study, n = 146, average RR 0.03, 95%
CI 0.00 to 0.44, Analysis 2.1). There was a statistically significant
decrease in operative birth (caesarean section, forceps or vacuum
birth) for nonreassuring fetal status when fetal pulse oximetry was
added to CTG monitoring, compared with CTG alone (FBS not
required prior to study entry, two studies, n = 1610, summary
RR 0.74, 95% CI 0.62 to 0.89, (Analysis 2.4). There was a large
decrease in the oximetry group for this outcome in the one study
(n = 146) where FBS was required prior to study entry (RR 0.05,
95% CI 0.01 to 0.22), (Kuhnert 2004).
There was no evidence of a difference in caesarean section for
dystociawhen fetal pulse oximetry (fetal pulse oximetry)was added
to CTG monitoring, compared with CTG monitoring alone (
Analysis 2.2).
The addition of fetal pulse oximetry to CTG monitoring resulted
in no evidence of differences for overall operative birth rates (with
the exception of the smaller study reported by Kuhnert 2004), en-
dometritis, intrapartum haemorrhage, postpartum haemorrhage,
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chorioamnionitis, endometritis, uterine rupture, length of hospital
stay, satisfaction with labour or satisfaction with fetal monitoring
in labour, compared to CTG only. No maternal deaths occurred.
The small study by Kuhnert 2004 reported less antibiotic use in
the fetal pulse oximetry group, compared with the CTG group.
Women reported similar levels of satisfaction with their labour
and fetal monitoring when fetal pulse oximetry was added to CTG
monitoring, compared to CTG monitoring alone (East 2006,
Analysis 2.13; Analysis 2.14).
The study by Valverde 2011 (n = 180), demonstrated a statistically
significant increase in caesarean section for nonreassuring fetal
status comparing fetal pulse oximetry plus CTG with fetal ECG
plusCTG(RR1.71, 95%CI1.01 to 2.88, Analysis 6.1), but not in
caesarean sectionperformed for dystocia (RR1.30, 95%CI0.60 to
2.81, Analysis 6.2). Therewas also a statistically significant increase
comparing fetal pulse oximetry plus CTG with fetal ECG plus
CTG in overall operative birth (RR 1.20, 95% CI 1.00 to 1.45,
Analysis 6.3) but not in overall operative birth for nonreassuring
fetal status (RR 1.22, 0.88 to 1.70, Analysis 6.4).
Secondary outcomes: fetal/neonatal
No evidence of significant differences was noted for Apgar scores
less than four at five minutes or less than seven at five minutes,
umbilical arterial pH less than 7.10, umbilical arterial base excess
less than -12, admission to the neonatal intensive care unit, length
of hospital stay, death, or skin trauma. Transient skin markings
attributable to the fetal oximetry sensor were noted in 11 of 638
babies (2%) Garite 2000; in 30 of 305 babies (10%) East 2006;
and for 152 of 2629 babies (6%) in the open oximetry values
group and 155 of 2712 babies (6%) in the masked group Bloom
2006.
The fetal oximetry plus CTG versus fetal ECG plus CTG study
by Valverde 2011 did not demonstrate any evidence of between-
group differences in admission to neonatal intensive care unit (n =
180, RR 1.00, 95% CI 0.06 to 15.74), (Analysis 7.1). Umbilical
arterial pH data from one study (Valverde 2011) were not in a
suitable format for inclusion in the RevMan software: the mean
(range) of pH in fetal pulse oximetry group was 7.23 (7.17 to
7.28) and in the fetal ECG group was 7.26 (7.20 to 7.29), which
the study authors noted to be a non-significant difference.
Subgroup analyses
Datawere available fromone trial (East 2006) to allow the planned
subgroup analyses of fetal scalp blood sampling post randomisa-
tion. There were no significant differences in the primary outcome
of caesarean section and no seizures were reported for any of the
babies in this subgroup. Data were not available to allow the re-
maining subgroup analyses to be conducted.
D I S C U S S I O N
Summary of main results
When systematically reviewed, five of the seven published trials
(with some unpublished data available), comparing fetal intra-
partum pulse oximetry with CTG or fetal electrocardiography or
masked fetal pulse oximetry, reported no difference in the overall
caesarean section rate between the fetal pulse oximetry group and
the CTG group. One smaller study did note a significant differ-
ence in favour of the fetal pulse oximetry plus CTG group. A study
comparing fetal pulse oximetry plus CTG and fetal electrocardio-
graphy plus CTG reported less caesarean section births in the fetal
electrocardiography plus CTG group.
Meta-analysis of the four studies with nonreassuring fetal status
from 34 weeks’ gestation prior to randomisation demonstrated a
reduction in caesarean section for nonreassuring fetal status, with
no differences in neonatal outcomes. That is, a decision not to
perform a caesarean section for nonreassuring fetal status in the
fetal pulse oximetry group did not result in worse outcomes for
those babies (but a larger sample would be required to demon-
strate a difference in such low-prevalence outcomes). There were
no between-group differences in caesarean section for nonreas-
suring fetal status when all participants in the largest study were
considered, when analysed without consideration of fetal status at
study entry.
The findings from more than 8000 participants provide substan-
tial evidence to suggest that knowledge of fetal pulse oximetry
values does not reduce overall caesarean section rates. However,
several issues warrant consideration. Firstly, does the indication
for caesarean section matter if the overall incidence of caesarean
section is the same, given than there is limited support from the
findings of this review, for the use of fetal pulse oximetry when
used in the presence of a nonreassuring CTG, to reduce caesarean
section for nonreassuring fetal status? An additional area of im-
portance is whether or not the presence of a fetal oximetry sensor
contributes to dystocia.
Overall completeness and applicability of
evidence
The decision pathway leading to performing a caesarean section
may be important. The additional information that fetal pulse
oximetry can provide, when a nonreassuring fetal heart rate trace
has been identified, may translate to avoidance of a caesarean sec-
tion for nonreassuring fetal status, with its associated stress levels
for the mother and resource implications for the health service
providers. An ’inevitable’ caesarean section may still be performed
for other indications, when the woman has had more time to con-
sider her options. Staffing levels can also be adjusted over a number
of hours, rather than the immediate and potentially costly provi-
13Fetal pulse oximetry for fetal assessment in labour (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
sion of staff for an emergency operation. One trial reported that
the addition of fetal pulse oximetry to CTG monitoring was cost
effective in reducing operative birth for nonreassuring fetal status
(East 2006).
Women’s reports of satisfaction with their labour and with fetal
monitoring were similar when fetal pulse oximetry was added to
CTG monitoring, compared to CTG monitoring alone. This is
an important consideration, given that the use of technology may
impact on women’s perceived control over their labour experience
(Wagner 2001). Although an ideal study would compare women’s
satisfaction with fetal pulse oximetry and without any technology,
such a study is not feasible. It can be considered, however, that
once continuous CTG monitoring is in use during labour, the
addition of fetal pulse oximetry technology does not adversely
affect women’s perceptions of their labour experience or of fetal
monitoring overall. Long-term neurodevelopmental outcome has
not been measured.
Quality of the evidence
Overall, the evidence (for the primary outcomes) was of moder-
ate to high quality. The impractical nature of blinding partici-
pants and clinicians in the intervention arm of each study was not
viewed as something that could be overcome and was consistent
across studies, meaning that any impact of this potential bias was
essentially the same for each study. The findings from the smallest
of the included studies (n = 146, Kuhnert 2004) were consider-
ably more positive for the primary outcome of caesarean section
than was noted in any of the remaining studies. This inconsistency
in findings is worthy of consideration when interpreting overall
results. The addition in this update of another small study (n =
180, Valverde 2011) resulted in an increase in caesarean section
rates for those in the fetal pulse oximetry group, compared with
CTG plus fetal ECG.Where meta-analysis was appropriate, there
was considerable heterogeneity, even when using random-effects,
meaning that larger sample sizes may be necessary to address the
outcomes of interest.
Potential biases in the review process
The authors are not aware of potential biases that have not already
been addressed through the rigorous methods adopted in this re-
view in line with those of the Cochrane Pregnancy and Childbirth
Group. The search strategy is believed to be robust in its ability
to identify all trials. The evaluation of the study that two of the
review authors had conducted (CE and PB: East 2006) by an in-
dependent author (LB) in the 2007 update of this review aimed
to minimise any potential reporting bias for that trial.
Agreements and disagreements with other
studies or reviews
European clinicians published guidelines for fetal pulse oximetry
use (Kuhnert 1998; Saling 1996) that were consistent with the
management of fetal pulse oximetry inGarite 2000 and prior to its
results being known. Only two small randomised controlled trials
of fetal pulse oximetry have since been reported from Europe to
test these guidelines (Kuhnert 2004; Valverde 2011). These trials
reported divergent findings (an increase in one and decrease in the
other) for overall caesarean section rates.
The American College of Obstetrics and Gynecology (ACOG)
reviewed the results of the trial reported by Garite 2000 and rec-
ommended further trials before the introduction of fetal pulse
oximetry into clinical practice (ACOG 2001). Their recommen-
dation was based mainly on the increase in dystocia reported with
the use of fetal pulse oximetry and the potential to increase fetal
monitoring costs without improving clinical outcomes (ACOG
2001). One trial reported that the addition of fetal pulse oximetry
to cardiotocography was cost effective in reducing operative birth
for nonreassuring fetal status (East 2006).
When the findings of the first trials of fetal pulse oximetry became
available, there was debate about why the incidence of caesarean
section for dystocia more than doubled from 9% in the CTG-only
group to 19% when fetal pulse oximetry was added. The investi-
gators explored several possible causes for the increase in dystocia
in the fetal pulse oximetry group, including potential mislabelling
of dystocia and the presence of the oximetry sensor slowing the
labour (Garite 2000). The authors concluded that mislabelling
of the indication for caesarean section had not occurred and the
presence of the sensor did not result in a longer labour. They sug-
gested that the nonreassuring CTG may indicate an underlying
risk for dystocia (Garite 2000). To test this hypothesis, Porreco
2004 conducted a multicentre, prospective, observational cohort
study of fetal pulse oximetry in nulliparous labouring women,
with a standardised labour management protocol and a specific
focus on the management of dystocia (defined). The investigators
concluded that the presence of persistent, progressive and mod-
erate to severely nonreassuring CTGs may predict the need for
birth by caesarean section for dystocia, despite adequate fetal oxy-
genation (Porreco 2004). No other trials in this systematic review
demonstrated a difference in caesarean section for dystocia. How-
ever, the incidence of dystocia in each trial varied: from 11% in
the fetal pulse oximetry group and 14% in the CTG-only group
(East 2006) to 19% for all women in both the open and masked
groups, where all participants had a fetal oximetry sensor placed
(Bloom 2006), whichwas similar to that of the fetal pulse oximetry
group of Garite 2000.The incidence of dystocia was much lower
in the study reported by Caliskan 2009 (2.6% in the fetal oxime-
try group and 3.4% in the CTG-only group). These researchers
considered that the intermittent use of the fetal oximetry probe
may have avoided an over representation of dystocia in the oxime-
try group. It remains possible that the presence of a fetal oximetry
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sensor alongside the fetal head contributes to dystocia.
The use of CTG has some parallels. Current clinical practice rec-
ommendations are that the clinician and the individual woman
should consider the appropriateness ofCTGto enable an informed
choice for each case (Alfirevic 2013; NICE 2007). Given the high
quality of evidence from several of the reported fetal pulse oxime-
try trials and the reduction in caesarean section for nonreassuring
fetal status (but not for overall caesarean section rates) in those for
which a nonreassuring CTG was required prior to study entry, it
may be prudent when developing recommendations to encourage
the individual woman and her clinicians to make the decision to
use or not use fetal pulse oximetry. Unlike CTG, however, the ran-
domised controlled trials of fetal pulse oximetry have been con-
ducted prior to widespread clinical acceptance and medico-legal
expectation of fetal pulse oximetry usage where there is concern
about fetal well-being.
Commercial availability of the fetal pulse oximetry system used
in the studies was discontinued during 2006. Other systems that
have not yet been subject to trials may still remain available com-
mercially.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This systematic review, comparing fetal intrapartum pulse oxime-
try with CTG or fetal electrocardiography or masked fetal pulse
oximetry, provided evidence of no effect on the overall caesarean
section rate between the fetal pulse oximetry group and the CTG
group. There was evidence of some effect in reducing caesarean
section rates for the indication of nonreassuring CTG when fe-
tal pulse oximetry was added to CTG. Therefore, the evidence
suggests that fetal pulse oximetry does not contribute to overall
clinical practice. A better method to evaluate fetal well-being in
labour is required.
Implications for research
Further trials could address: entry criteria related to the severity of
nonreassuring CTG patterns; action levels for fetal pulse oximetry
values, such as a decline by 10% or 20%, rather than an absolute
cut-off value; and the endpoint of long-term neurodevelopmental
outcomes. The ideal study to address the issue of dystocia when a
fetal pulse oximetry sensor is placed alongside the fetal head would
compare caesarean section for dystocia in three groups: those with
fetal oximetry displayed, those with fetal pulse oximetry masked
and those without fetal pulse oximetry. Further studies using fetal
oximetry sensors attached to the fetal scalp, rather than placed
alongside the fetal head, could also be considered.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bloom 2006
Methods RCT.
Participants Nulliparous women from 36 weeks’ gestation with a singleton pregnancy and cephalic
presentation, in early labour (2-5 cm cervical dilatation) with ruptured amniotic mem-
branes who gave informed consent
Interventions ’Open’ group: FPO sensor placed and FPO values displayed.
’Masked’ group: FPO sensor placed and FPO values not displayed (FPO values recorded
on computer)
Both groups: standard fetal heart rate monitoring; labour management at the clinician’s
discretion
Outcomes Primary: caesarean section (any indication).
Secondary: caesarean section for nonreassuring fetal status or dystocia; “fetal vulnerability
index” (stillbirth, neonatal death, 5-min Apgar score less than 3, umbilical pH less than
or equal to 7, seizures, admission to NICU for greater than or equal to 24 hours); other
neonatal morbidity
Notes Fetal oximetry system used: Nellcor OxiFirst.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk After the fetal oximetry sensor was placed, randomisation was
performed by a research nurse using an encrypted computer
program
Allocation concealment (selection bias) Low risk After the fetal oximetry sensor was placed, randomisation was
performed by a research nurse using an encrypted computer
program
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of intervention: women and clinicians were blinded
to FPO values in the ’masked’ group: however, they were not
actually blinded to intervention. It would not have been feasible
to fully blind the clinician or participant, given that FSpO2
values were used for clinical judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Research nurses obtained data from the maternal and infant
charts. Adverse maternal outcomes (placental abruption or pro-
longed fetal heart rate deceleration at the time of sensor place-
ment) and the composite neonatal outcome were further veri-
fied by investigators. “Chart reviewers had no knowledge of the
randomization assignment” (p2198)
20Fetal pulse oximetry for fetal assessment in labour (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bloom 2006 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk The published protocol noted the aim of recruiting 10,000
women. When 5017 women had been recruited and their out-
comes examined at the third interim analysis. the Data Safety
andMoniritoringCommittee advised that sufficient recruitment
had been undertaken to detect the 15% difference in the pri-
mary outcome of caesarean section rate with 90% power (as the
higher than expected caesarean section rate once the trial was
underway). Recruitment ceased once this decision was agreed
upon, with a total of 5341 women randomised and their out-
comes analysed
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Other bias Low risk No evidence of other bias. The report aligns with the limited
details available in the protocol published when the RCT was in
progress (see attrition bias)
Caliskan 2009
Methods RCT, single centre (Turkey).
Participants Women from 34 weeks’ gestation undergoing induction of labour with oral misoprostol
Inclusion: singleton live pregnancy with vertex presentation and maternal and/or fetal
indications for induction of labour; gestational age from 34 weeks; Bishop score less than
or equal to 5; absence of spontaneous uterine contractions; estimated fetal body weight
less than 4250 g; reactive non-stress test
Exclusion: fetal demise; gestational age less than 34 weeks; known hypersensitivity to
prostaglandin; previous caesarean section or other uterine surgery; contraindication to
vaginal birth
Interventions Group 1: electronic fetal monitoring by CTG only. If the CTG was reassuring, labour
continued unless otherwise indicated. If the CTG was nonreassuring (defined), simple
measures, including lateral positioning, were instigated, with escalation to operative birth
if simple measures were not effective
Group 2: CTG plus FSpO2 monitoring - intermittently for 15 minutes every 2 hours. If
reassuring it was removed. If nonreassuring, remained in situ. If the CTG was reassuring
and FSpO2 values were greater than or equal to 30%, labour continued unless otherwise
indicated. If the CTGwas nonreassuring (defined) and FSpO2 values were less than 30%
for 3 minutes, simple measures, including lateral positioning, were instigated. If FSpO2
values remained < 30% for 10 minutes, then operative birth was performed
Outcomes Primary outcome: caesarean birth rates.
Secondary outcomes: induction to birth interval, caesarean section for nonreassuring
CTG, neonatal outcomes, including umbilical arterial pH < 7.16, admission to neonatal
intensive care
21Fetal pulse oximetry for fetal assessment in labour (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Caliskan 2009 (Continued)
Notes Fetal oximetry system used: Nellcor OxiFirst.
37 weeks used as ’restriction point’ to randomly allocate preterm and term fetuses to
the 2 groups. This is interpreted as stratification by term/preterm, however, no further
details provided of outcomes within these groups
Datawere not available to allow subgroup analysis in this review by term/preterm. Similar
numbers of term (total n = 195)/preterm (total n = 35) were randomised to the control
and intervention groups, with the larger proportion being term in each group. There
were similar neonatal outcomes (including birthweight and admission to NICU), both
between the groups and compared with other studies enrolling over 36 weeks. We have
therefore included these participants in the analyses of later gestations, renaming the
analyses that include participants from this study as “... gestation from 34 weeks ...”
Attempts at establishing contact details to clarify this were unsuccessful
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-based randomisation reported to be “Di-
rected by a physician”
Allocation concealment (selection bias) Low risk Sequentially numbered opaque envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were unblinded. It would not have been
feasible to blind the clinician or participant, given that
FSpO2 values were used for clinical judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The authors did not state whether or not outcome as-
sessment was blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk A flowchart of the eligible and enrolled participants was
included in the publication and outcomes were reported
for all these participants
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Other bias Low risk No evidence of other bias, although there is no evidence
of trial registration or study protocol publication
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East 2006
Methods Multicentre RCT.
Survey of women’s perceptions: identical surveys to participants in each group within a
few days of giving birth and 3 months later. Women were asked to rate their experience
in 3 domains: labour (maximum score 12), fetal monitoring (maximum score 16) and
participation in research (maximum score 12).
Cost-effectiveness analysis the RCT. Costs included diagnosis-related group costs, FBS,
medications, use of oxygen or intravenous fluid, or both, FPO. Effect was the primary
outcome of the RCT (operative birth for nonreassuring fetal status)
Participants 601 women in labour. 1 exclusion, leaving 600 analysed.
Inclusion criteria: nonreassuring CTG (defined),
>
= 36 weeks’ gestation, early or active
labour, ruptured amniotic membranes or eligible for artificial rupture of membranes
Exclusion criteria: multiple gestations, non vertex presentation, placenta praevia, abrup-
tio placentae, uterine anomaly, antepartum haemorrhage, fetal anomaly, known signifi-
cant viral infections (e.g. HIV), any other contraindications to invasive monitoring such
as thrombocytopenia
Interventions Control group: fetal heart rate monitoring (CTG) (doppler/fetal scalp electrode)
Intervention group: CTG plus fetal pulse oximetry. Protocol for action with reassuring (
>
=
30%) and nonreassuring fetal oximetry values (< 30% for 10 minutes, or not recording)
Outcomes Primary outcome: operative birth (caesarean section, vacuum, forceps) for nonreassuring
fetal status
Maternal outcomes including: caesarean section and assisted vaginal birth for nonre-
assuring fetal status; caesarean and assisted vaginal birth section for dystocia/failure to
progress; caesarean or assisted vaginal birth for combined indication of nonreassuring
fetal status and dystocia; caesarean section; assisted vaginal birth; spontaneous vaginal
birth; labour interventions and fetal evaluations (e.g. scalp pH); endometritis; postpar-
tum haemorrhage; length of stay
Women’s perceptions: satisfaction measured in 3 domains: labour, fetal monitoring and
participation in research
Neonatal outcomes including: Apgar scores; umbilical cord blood gases; resuscitation;
admission to NICU; length of hospital stay
Economic analysis: cost-effectiveness of FPO to prevent operative birth for nonreassuring
fetal status
Notes Sample size calculation: yes, based on reduction in caesarean section rate for nonreassur-
ing fetal status.
Fetal oximetry system used: Nellcor OxiFirst.
Women’s perceptions: results from the first survey are used in this report
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Developed by a research associate not in-
volved in recruitment
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East 2006 (Continued)
Allocation concealment (selection bias) Low risk Adequate, through use of password pro-
tected computer randomisation system
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were unblinded. It would not
have been feasible to blind the clinician or
participant, given that FSpO2 values were
used for clinical judgement
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Initial analyses were done with blinded
group allocation, followed by unblinded
analyses
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data from all participants were
accounted for.
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Other bias High risk Authors declared commercial funding in all
publications. Limited protocol details were
available online through a perinatal trials
registry. The unpublished ethics-approved
study protocol was available to those assess-
ing these risks of bias
Garite 2000
Methods Random allocation: telephone randomisation.
Participants 1189 women in labour. This consisted of 1010 in the published trial and 179 in a pilot
of the trial conducted using the same protocol, where unpublished data were accessible
Inclusion criteria: nonreassuring CTG,
>
= 36 weeks’ gestation, active labour, single fetus,
cephalic presentation, cervical dilatation of at least 2 cm and at station -2 or below,
ruptured amniotic membranes (or have amniotomy)
Exclusion criteria: planned caesarean section, placenta praevia, need for immediate birth,
active genital herpes or known HIV infection, participation in other studies
Interventions Control group: fetal heart rate monitoring (CTG) (doppler/fetal scalp electrode)
Study group: CTG plus fetal pulse oximetry. Protocol for action with reassuring and
nonreassuring fetal oximetry values
Outcomes Caesarean section for nonreassuring status; caesarean section for all indications; caesarean
section for fetal intolerance to labour with dystocia, mixed indication; caesarean dystocia,
single indication; spontaneous vaginal birth; assisted vaginal birth for nonreassuring fetal
status or for all other indications; fetal heart rate patterns; labour interventions and fetal
evaluations (e.g. scalp pH)
Neonatal outcomes including: Apgar scores; umbilical cord blood gases; resuscitation;
admission to NICU; length of hospital stay
Maternal outcomes including: endometritis; length of stay; bleeding; uterine rupture;
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Garite 2000 (Continued)
intrapartum fever
Notes Some additional unpublished data from a pilot of the trial, using the same protocol, were
available.
Further data were requested but were unable to be accessed.
Sample size calculation: yes, based on reduction in caesarean section rate for nonreassur-
ing fetal status.
Fetal oximetry system used: Nellcor OxiFirst.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation.
Allocation concealment (selection bias) Low risk Adequate, with computer randomisation.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants andpersonnel were unblinded.
It would not have been feasible to blind,
given that the FSpO2 values were used in
decision making
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Only some outcome analysis was blinded,
e.g. retrospective examination of par-
tograms to determine diagnosis of dystocia
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data.
“All analyses ... included all randomizedpa-
tients” (p1053)
Selective reporting (reporting bias) Low risk No evidence of selective reporting. Avail-
able data for this review included a report to
the Food and Drug Administration, which
include comprehensive and otherwise un-
published results that were consistent with
published findings
Other bias High risk Commercially funded study, which was ac-
knowledged by report authors. The study
protocol was publicly available during the
trial
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Klauser 2005
Methods Single-centre RCT.
Participants 360 women in labour. Control group: 1 post randomisation exclusion as no consent.
Intervention group: 30 post randomisation exclusions where FPO sensor not placed and
2 additional exclusions due to randomisation issues
Inclusion criteria: nonreassuring CTG,
>
= 28 weeks’ gestation, single fetus, cephalic pre-
sentation, cervical dilatation of at least 2 cm and at station -5 or below, ruptured amniotic
membranes (spontaneous or artificial)
Exclusion criteria: planned caesarean section, contraindication to vaginal birth (including
genital herpes, transverse lie), unexplained vaginal bleeding, placenta praevia, ominous
CTG requiring immediate birth, known HIV infection, hepatitis B or C, unable to give
consent due to intrapartum parenteral analgesia
Interventions Control group: fetal heart rate monitoring (CTG) (Doppler/fetal scalp electrode)
Study group: CTG plus fetal pulse oximetry (Nellcor OxiFirst). Protocol for action with
reassuring fetal oximetry (
>
= ≥30%) and nonreassuring values (< 30% for 3 minutes)
Outcomes Primary outcome: caesarean section for nonreassuring fetal status
Maternal outcomes: caesarean section for all indications; caesarean section for dystocia;
amnioinfusion and length of labour
Neonatal outcomes including: Apgar scores; umbilical cord blood gases; resuscitation;
admission to NICU
Notes Further data were requested, no response.
Sample size calculation: yes, based on reduction in caesarean section rate for nonreas-
suring fetal status. This was revised following the interim analysis due to a higher than
anticipated caesarean section rate in the control group, meaning that a 50% reduction
in caesareans would require less participants than originally though. The study ceased at
that time.
Fetal oximetry system used: Nellcor OxiFirst.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of randomisation not stated. No response from
request to the authors for clarification
Allocation concealment (selection bias) Unclear risk Unclear. No mention in the report, although two participants
were excluded on the basis of “randomization issues”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were unblinded. It would not have been feasible to
blind the clinician or participant, given that FSpO2 values were
used for clinical judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is unclear if the outcome assessors were blinded to group
allocation
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Klauser 2005 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data - the flowchart in the
published report accounts for all those enrolled. The trial was
ceased following an interim analysis, at which time it was de-
termined that a total of 300 of the original planned 400 would
have adequate power to detect a 50% reduction in the primary
outcome, caesarean section. Some recruitment occurred while
the interim analysis was in progress, meaning that a total of 327
women were randomised. Of these, there were 32 postrandomi-
sation exclusions in the fetal oximetry group and 1 in the control
group,
Selective reporting (reporting bias) Low risk No evidence of selective reporting. The flowchart in the pub-
lished report accounts for all those enrolled
Other bias Low risk No evidence of other bias, although there is no evidence of trial
registration or study protocol publication
Kuhnert 2004
Methods Single-centre, RCT.
Participants 146 women in labour.
Inclusion criteria: CTG with International Federation of Gynecology and Obstetrics
(FIGO) score
<
= 8, gestational age
>
= 36 weeks, active labour, single fetus, cephalic presen-
tation, cervical dilatation of at least 2 cm and at station -2 or below, ruptured amniotic
membranes (or have amniotomy). All cases had FBS prior to randomisation
Exclusion criteria: planned caesarean section, placenta praevia, need for immediate birth,
active genital herpes or known HIV infection
Interventions Control group: fetal heart rate monitoring (CTG) and FBS. Protocol for action with
reassuring, suspicious and pathologic CTG and FBS pH values
Intervention group: CTG plus FBS plus FPO. Protocol for action with reassuring (
>
=
30%) and nonreassuring FPO values (< 30% for
>
= 10 mins or repeatedly (’summation
effect’)), and for reassuring and nonreassuring CTG and FBS pH
Outcomes Caesarean section or vacuum extraction for pathologic CTG; caesarean section or vac-
uum extraction for all indications; caesarean section or vacuum for arrest of labour; cae-
sarean section for pelvic malformation or amnioinfection; vacuum extraction for mater-
nal exhaustion; spontaneous vaginal birth; fetal heart rate patterns; FBS (including pH)
Neonatal outcomes including: umbilical cord blood gases; resuscitation; admission to
NICU
Maternal outcomes: ’adverse maternal events’.
Notes Some additional unpublished data were provided by the authors (use of antibiotics,
haemorrhage, chorioamnionitis, endometritis, uterine rupture, length of hospital stay,
satisfaction with labour and fetal monitoring, death, neonatal skin trauma, Apgar score,
umbilical arterial base excess, admission to neonatal intensive care, hypoxic-ischaemic
encephalopathy, seizures, long-term disability). No details of the assessment of long-term
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Kuhnert 2004 (Continued)
disability were provided (e.g. age of the infant, assessments made)
Sample size calculation: no.
Fetal oximetry system used: Nellcor OxiFirst.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random allocation: method not stated and not provided on
request
Allocation concealment (selection bias) Unclear risk Unclear. No details provided in the report.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were unblinded. It would not have been feasible to
blind the clinician or participant, given that FSpO2 values were
used for clinical judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The report states “data acquisition was done anonymously for
both groups”. It is unclear whether this related to de-identifying
the data (likely) or that the data were collected without knowl-
edge of group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data.
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Other bias Unclear risk The results are very different to those of the other studies in this
review
No evidence of other bias, although there is no evidence of trial
registration or study protocol publication
Valverde 2011
Methods Prospective RCT.
Participants Pregnant women with a full-term singleton fetus in cephalic presentation admitted to
the dilatation and birth sections of the Department of Obstetrics and Gynecology at
Virgen de las Nieves University Hospital in Granada, Spain
NRFHR patterns were recorded during the second stage of labour as per Garite et al.
2000
N = 90 in each group.
Interventions Group 1: pulse oximetry and intrapartum CTG.
Group 2: fetal ECG (spiral electrode on the scalp) and intrapartum CTG
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Valverde 2011 (Continued)
Outcomes Maternal: outcome of labour, rate of caesarean birth, rate of intervention due toNRFHR,
reason for the intervention, duration of each stage of labour
Neonatal: cord blood acid base (arterial and venous), Apgar score, type of resuscitation,
rate of admission to the NICU
Notes After informed consent was obtained, an examination was performed to determine fetal
well-being with the scalp stimulation test and membranes were ruptured, if they had not
already ruptured
All participants were offered epidural anaesthesia.
Fetal oximetry: FS14 sensor and Nellcor 400 Fetal Oxygen Saturation Monitoring Sys-
tem. Normal values FSpO2 were defined as between 30% and 70%, with 30% as the
cut-off value. If FSpO2 below 10%, labour was terminated and between 10% and 30%
additional information to determine the fetus’s acid-base was sought
Fetal ECG: : Electrode Cetro AB, Neoventa, Molndal, Sweden.
We have had no response from the authors to our request for the study protocol or
whether or not the sealed opaque randomisation envelopes were sequentially numbered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table.
Allocation concealment (selection bias) Unclear risk Sealed opaque envelopes. It is unclear whether or not these were
sequentially numbered
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were unblinded. It would not have been feasible to
blind the clinician or participant, given that FSpO2 values were
used for clinical judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The report does not state whether or not outcome assessors
were blinded to group allocation. Clarification from authors was
sought, with no response
Incomplete outcome data (attrition bias)
All outcomes
Low risk No attrition was reported and relevant results were reported for
all 180 participants
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Other bias Low risk No evidence of other bias, although there is no evidence of trial
registration or study protocol publication
CTG: cardiotocography
ECG: fetal electrocardiography
FBS: fetal blood sampling (scalp)
FPO: fetal pulse oximetry
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FSpO2: fetal oxygen saturation value
HIV: human immunodeficiency virus
NICU: neonatal intensive care unit
NRFHR: nonreassuring fetal heart rate
min: minute
RCT: randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Andres 2004 This study was conducted in Spain. It compared caesarean section rates for pathological or nonreassuring CTG
when FPO was added to CTG monitoring or when FPO was not used. The groups were not randomised
Golaszewski 1993 This was an observational study of fetal pulse oximetry, where participants were randomised to be monitored
with 1 of 2 oximeters
CTG: cardiotocography
FPO: fetal pulse oximetry
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D A T A A N D A N A L Y S E S
Comparison 1. Primary outcomes: FPO + CTG versus CTG only
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section 6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Gestation from 34 weeks,
FBS not required prior to study
entry
4 4008 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.86, 1.13]
1.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.44 [0.24, 0.81]
1.3 Gestation from 28 weeks,
FBS not required prior to study
entry
1 327 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.76, 1.14]
1.4 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.87, 1.04]
2 Hypoxic-ischaemic
encephalopathy
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 600 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.44]
3 Neonatal seizures 4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.10, 8.79]
3.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Random, 95% CI) 0.62 [0.15, 2.59]
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Comparison 2. Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section for
nonreassuring fetal status
6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Gestation from 34 weeks,
FBS not required prior to study
entry
4 4008 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.46, 0.90]
1.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.03 [0.00, 0.44]
1.3 Gestation from 28 weeks,
FBS not required prior to study
entry
1 327 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.64, 1.24]
1.4 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.75, 1.09]
2 Caesarean section for dystocia 6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Gestation from 34 weeks,
FBS not required prior to study
entry
4 4008 Risk Ratio (M-H, Random, 95% CI) 1.38 [0.91, 2.09]
2.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 1.4 [0.47, 4.21]
2.3 Gestation from 28 weeks,
FBS not required prior to study
entry
1 327 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.66, 1.46]
2.4 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Random, 95% CI) 0.97 [0.87, 1.08]
3 Operative birth (caesarean
section, forceps, vacuum
extraction) for all indications
5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Gestation from 34 weeks,
FBS not required prior to study
entry
3 1840 Risk Ratio (M-H, Random, 95% CI) 1.03 [0.92, 1.15]
3.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.36, 0.73]
3.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.90, 1.03]
4 Operative birth (caesarean
section, forceps, vacuum) for
nonreassuring fetal status
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1610 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.62, 0.89]
4.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.05 [0.01, 0.22]
5 Use of intrapartum antibiotics 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
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5.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 600 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.87, 1.35]
5.2 Gestation from 36 weeks,
FBS required prior to study
entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.52 [0.30, 0.88]
6 Overall antibiotic use 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.52 [0.30, 0.88]
7 Intrapartum haemorrhage 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1610 Risk Ratio (M-H, Fixed, 95% CI) 1.50 [0.52, 4.34]
7.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.69]
8 Postpartum haemorrhage 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
8.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Random, 95% CI) 1.52 [0.53, 4.39]
8.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
9 Chorioamnionitis 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.11, 3.87]
9.2 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.86, 1.17]
10 Endometritis 4 7276 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.79, 1.26]
10.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.61, 2.12]
10.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.76, 1.26]
11 Uterine rupture 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.12, 6.13]
11.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Length of hospital stay (days) 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
12.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 600 Mean Difference (IV, Fixed, 95% CI) -0.06 [-0.36, 0.24]
12.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.65, 0.65]
13 Satisfaction with labour 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
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13.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 448 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.16, 0.56]
14 Satisfaction with fetal
monitoring in labour
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
14.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 448 Mean Difference (IV, Fixed, 95% CI) 0.40 [-0.05, 0.85]
15 Death 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
15.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 3. Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Apgar score less than 4 at 5
minutes
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Fixed, 95% CI) 2.60 [0.11, 63.70]
1.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Fixed, 95% CI) 2.06 [0.52, 8.24]
2 Apgar score less than 7 at 5
minutes
5 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Gestation from 34 weeks,
FBS not required prior to study
entry
3 2019 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.38, 1.18]
2.2 Gestation from 36 weeks,
FBS required prior to study
entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.12, 72.45]
2.3 Gestation from 28 weeks,
FBS not required prior to study
entry
1 327 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.17, 2.91]
3 Length of hospital stay (days) 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 600 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.33, 0.33]
3.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.32, 0.32]
4 Umbilical arterial pH less than
7.10
4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
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4.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1701 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.66, 1.53]
4.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.17 [0.02, 1.35]
4.3 Gestation from 28 weeks,
FBS not required prior to study
entry
1 327 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.17, 1.24]
5 Umbilical arterial base excess less
than -12
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1670 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.58, 1.92]
5.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.14, 6.91]
6 Admission to neonatal intensive
care unit
6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Gestation from 34 weeks,
FBS not required prior to study
entry
3 2019 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.84, 1.39]
6.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.30, 3.31]
6.3 Gestation from 28 weeks,
FBS not required prior to study
entry
1 327 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.55, 1.63]
6.4 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.70, 1.11]
7 Death 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.20, 3.97]
7.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.44]
8 Death, hypoxic-ischaemic
encephalopathy, or both
4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
8.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.20, 4.44]
8.2 Gestation from 36 weeks,
FBS required prior to study
entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
8.3 Gestation from 36 weeks,
nonreassuring fetal status not
required prior to study entry
1 5341 Risk Ratio (M-H, Random, 95% CI) 0.21 [0.01, 4.30]
9 Death, seizures, or both 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
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9.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.22, 3.55]
9.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
10 Death, long-term
neurodevelopmental problem,
or both
3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
10.1 Gestation from 36 weeks,
FBS not required prior to study
entry
2 1789 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.20, 4.44]
10.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
11 Skin trauma 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
11.1 Gestation from 36 weeks,
FBS not required prior to study
entry
1 600 Risk Ratio (M-H, Random, 95% CI) 0.73 [0.16, 3.21]
11.2 Gestation from 36 weeks,
FBS prior to study entry
1 146 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 4. Subgroup: fetal blood sampling: primary outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2 Neonatal seizures 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
Comparison 5. Primary outcomes: FPO + CTG versus fetal ECG + CTG
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section 1 180 Risk Ratio (M-H, Fixed, 95% CI) 1.56 [1.06, 2.29]
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Comparison 6. Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section for
nonreassuring fetal status
1 180 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [1.01, 2.88]
2 Caesarean section for dystocia 1 180 Risk Ratio (M-H, Fixed, 95% CI) 1.3 [0.60, 2.81]
3 Operative birth (caesarean
section, forceps, vacuum)
1 180 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [1.00, 1.45]
4 Operative birth (caesarean
section, forceps, vacuum) for
nonreassuring fetal status
1 180 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.88, 1.70]
Comparison 7. Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Admission to neonatal intensive
care unit
1 180 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.74]
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Analysis 1.1. Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 1 Caesarean
section.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 1 Primary outcomes: FPO + CTG versus CTG only
Outcome: 1 Caesarean section
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 34 weeks, FBS not required prior to study entry
Garite 2000 147/508 130/502 25.3 % 1.12 [ 0.91, 1.37 ]
East 2006 140/305 142/295 30.2 % 0.95 [ 0.80, 1.13 ]
Bloom 2006 327/1055 339/1113 38.5 % 1.02 [ 0.90, 1.15 ]
Caliskan 2009 18/114 31/116 6.0 % 0.59 [ 0.35, 0.99 ]
Subtotal (95% CI) 1982 2026 100.0 % 0.99 [ 0.86, 1.13 ]
Total events: 632 (FPO + CTG), 642 (CTG only)
Heterogeneity: Tau2 = 0.01; Chi2 = 5.47, df = 3 (P = 0.14); I2 =45%
Test for overall effect: Z = 0.16 (P = 0.87)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 12/73 27/73 100.0 % 0.44 [ 0.24, 0.81 ]
Subtotal (95% CI) 73 73 100.0 % 0.44 [ 0.24, 0.81 ]
Total events: 12 (FPO + CTG), 27 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 2.66 (P = 0.0078)
3 Gestation from 28 weeks, FBS not required prior to study entry
Klauser 2005 77/150 98/177 100.0 % 0.93 [ 0.76, 1.14 ]
Subtotal (95% CI) 150 177 100.0 % 0.93 [ 0.76, 1.14 ]
Total events: 77 (FPO + CTG), 98 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 692/2629 747/2712 100.0 % 0.96 [ 0.87, 1.04 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.96 [ 0.87, 1.04 ]
Total events: 692 (FPO + CTG), 747 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
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Analysis 1.2. Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 2 Hypoxic-
ischaemic encephalopathy.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 1 Primary outcomes: FPO + CTG versus CTG only
Outcome: 2 Hypoxic-ischaemic encephalopathy
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 0/305 0/295 Not estimable
Subtotal (95% CI) 305 295 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 0/2629 1/2712 100.0 % 0.34 [ 0.01, 8.44 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.34 [ 0.01, 8.44 ]
Total events: 0 (FPO + CTG), 1 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.51)
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Analysis 1.3. Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 3 Neonatal seizures.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 1 Primary outcomes: FPO + CTG versus CTG only
Outcome: 3 Neonatal seizures
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 0/637 1/552 50.0 % 0.29 [ 0.01, 7.08 ]
East 2006 1/305 0/295 50.0 % 2.90 [ 0.12, 70.95 ]
Subtotal (95% CI) 942 847 100.0 % 0.92 [ 0.10, 8.79 ]
Total events: 1 (FPO + CTG), 1 (CTG only)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.00, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 0.08 (P = 0.94)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 3/2629 5/2712 100.0 % 0.62 [ 0.15, 2.59 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.62 [ 0.15, 2.59 ]
Total events: 3 (FPO + CTG), 5 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
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Analysis 2.1. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 1
Caesarean section for nonreassuring fetal status.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 1 Caesarean section for nonreassuring fetal status
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 34 weeks, FBS not required prior to study entry
Garite 2000 23/508 51/502 22.5 % 0.45 [ 0.28, 0.72 ]
East 2006 42/305 59/295 28.0 % 0.69 [ 0.48, 0.99 ]
Bloom 2006 104/1055 123/1113 33.9 % 0.89 [ 0.70, 1.14 ]
Caliskan 2009 11/114 23/116 15.6 % 0.49 [ 0.25, 0.95 ]
Subtotal (95% CI) 1982 2026 100.0 % 0.65 [ 0.46, 0.90 ]
Total events: 180 (FPO + CTG), 256 (CTG only)
Heterogeneity: Tau2 = 0.07; Chi2 = 8.16, df = 3 (P = 0.04); I2 =63%
Test for overall effect: Z = 2.56 (P = 0.010)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 18/73 100.0 % 0.03 [ 0.00, 0.44 ]
Subtotal (95% CI) 73 73 100.0 % 0.03 [ 0.00, 0.44 ]
Total events: 0 (FPO + CTG), 18 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 2.54 (P = 0.011)
3 Gestation from 28 weeks, FBS not required prior to study entry
Klauser 2005 43/150 57/177 100.0 % 0.89 [ 0.64, 1.24 ]
Subtotal (95% CI) 150 177 100.0 % 0.89 [ 0.64, 1.24 ]
Total events: 43 (FPO + CTG), 57 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 187/2629 213/2712 100.0 % 0.91 [ 0.75, 1.09 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.91 [ 0.75, 1.09 ]
Total events: 187 (FPO + CTG), 213 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
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Analysis 2.2. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 2
Caesarean section for dystocia.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 2 Caesarean section for dystocia
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 34 weeks, FBS not required prior to study entry
Garite 2000 94/508 43/502 30.4 % 2.16 [ 1.54, 3.03 ]
East 2006 44/305 32/295 27.2 % 1.33 [ 0.87, 2.04 ]
Bloom 2006 216/1055 210/1113 35.9 % 1.09 [ 0.92, 1.29 ]
Caliskan 2009 3/114 4/116 6.5 % 0.76 [ 0.17, 3.33 ]
Subtotal (95% CI) 1982 2026 100.0 % 1.38 [ 0.91, 2.09 ]
Total events: 357 (FPO + CTG), 289 (CTG only)
Heterogeneity: Tau2 = 0.12; Chi2 = 13.22, df = 3 (P = 0.004); I2 =77%
Test for overall effect: Z = 1.53 (P = 0.13)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 7/73 5/73 100.0 % 1.40 [ 0.47, 4.21 ]
Subtotal (95% CI) 73 73 100.0 % 1.40 [ 0.47, 4.21 ]
Total events: 7 (FPO + CTG), 5 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
3 Gestation from 28 weeks, FBS not required prior to study entry
Klauser 2005 34/150 41/177 100.0 % 0.98 [ 0.66, 1.46 ]
Subtotal (95% CI) 150 177 100.0 % 0.98 [ 0.66, 1.46 ]
Total events: 34 (FPO + CTG), 41 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.92)
4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 490/2629 521/2712 100.0 % 0.97 [ 0.87, 1.08 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.97 [ 0.87, 1.08 ]
Total events: 490 (FPO + CTG), 521 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.53 (P = 0.59)
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Analysis 2.3. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 3
Operative birth (caesarean section, forceps, vacuum extraction) for all indications.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 3 Operative birth (caesarean section, forceps, vacuum extraction) for all indications
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 34 weeks, FBS not required prior to study entry
Garite 2000 267/508 247/502 43.0 % 1.07 [ 0.95, 1.21 ]
East 2006 224/305 209/295 51.4 % 1.04 [ 0.94, 1.15 ]
Caliskan 2009 23/114 34/116 5.6 % 0.69 [ 0.43, 1.09 ]
Subtotal (95% CI) 927 913 100.0 % 1.03 [ 0.92, 1.15 ]
Total events: 514 (FPO + CTG), 490 (CTG only)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.30, df = 2 (P = 0.19); I2 =39%
Test for overall effect: Z = 0.45 (P = 0.65)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 25/73 49/73 100.0 % 0.51 [ 0.36, 0.73 ]
Subtotal (95% CI) 73 73 100.0 % 0.51 [ 0.36, 0.73 ]
Total events: 25 (FPO + CTG), 49 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 3.70 (P = 0.00021)
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 1072/2629 1147/2712 100.0 % 0.96 [ 0.90, 1.03 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.96 [ 0.90, 1.03 ]
Total events: 1072 (FPO + CTG), 1147 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
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Analysis 2.4. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 4
Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 78/508 108/502 52.9 % 0.71 [ 0.55, 0.93 ]
East 2006 76/305 95/295 47.1 % 0.77 [ 0.60, 1.00 ]
Subtotal (95% CI) 813 797 100.0 % 0.74 [ 0.62, 0.89 ]
Total events: 154 (FPO + CTG), 203 (CTG only)
Heterogeneity: Chi2 = 0.19, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 3.18 (P = 0.0015)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 2/73 37/73 100.0 % 0.05 [ 0.01, 0.22 ]
Subtotal (95% CI) 73 73 100.0 % 0.05 [ 0.01, 0.22 ]
Total events: 2 (FPO + CTG), 37 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 4.13 (P = 0.000037)
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Analysis 2.5. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 5 Use
of intrapartum antibiotics.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 5 Use of intrapartum antibiotics
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 110/305 98/295 100.0 % 1.09 [ 0.87, 1.35 ]
Subtotal (95% CI) 305 295 100.0 % 1.09 [ 0.87, 1.35 ]
Total events: 110 (FPO + CTG), 98 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.46)
2 Gestation from 36 weeks, FBS required prior to study entry
Kuhnert 2004 15/73 29/73 100.0 % 0.52 [ 0.30, 0.88 ]
Subtotal (95% CI) 73 73 100.0 % 0.52 [ 0.30, 0.88 ]
Total events: 15 (FPO + CTG), 29 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 2.43 (P = 0.015)
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Analysis 2.6. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 6
Overall antibiotic use.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 6 Overall antibiotic use
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 15/73 29/73 100.0 % 0.52 [ 0.30, 0.88 ]
Subtotal (95% CI) 73 73 100.0 % 0.52 [ 0.30, 0.88 ]
Total events: 15 (FPO + CTG), 29 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 2.43 (P = 0.015)
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Analysis 2.7. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 7
Intrapartum haemorrhage.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 7 Intrapartum haemorrhage
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 1/508 0/502 9.0 % 2.96 [ 0.12, 72.60 ]
East 2006 7/305 5/295 91.0 % 1.35 [ 0.43, 4.22 ]
Subtotal (95% CI) 813 797 100.0 % 1.50 [ 0.52, 4.34 ]
Total events: 8 (FPO + CTG), 5 (CTG only)
Heterogeneity: Chi2 = 0.21, df = 1 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.46)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 1/73 1/73 100.0 % 1.00 [ 0.06, 15.69 ]
Subtotal (95% CI) 73 73 100.0 % 1.00 [ 0.06, 15.69 ]
Total events: 1 (FPO + CTG), 1 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
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Analysis 2.8. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 8
Postpartum haemorrhage.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 8 Postpartum haemorrhage
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 19/637 17/552 59.0 % 0.97 [ 0.51, 1.84 ]
East 2006 12/305 4/295 41.0 % 2.90 [ 0.95, 8.89 ]
Subtotal (95% CI) 942 847 100.0 % 1.52 [ 0.53, 4.39 ]
Total events: 31 (FPO + CTG), 21 (CTG only)
Heterogeneity: Tau2 = 0.39; Chi2 = 2.79, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 0.77 (P = 0.44)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 2.9. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 9
Chorioamnionitis.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 9 Chorioamnionitis
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 2/73 3/73 100.0 % 0.67 [ 0.11, 3.87 ]
Subtotal (95% CI) 73 73 100.0 % 0.67 [ 0.11, 3.87 ]
Total events: 2 (FPO + CTG), 3 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
2 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 282/2629 291/2712 100.0 % 1.00 [ 0.86, 1.17 ]
Subtotal (95% CI) 2629 2712 100.0 % 1.00 [ 0.86, 1.17 ]
Total events: 282 (FPO + CTG), 291 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.00 (P = 1.0)
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Analysis 2.10. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 10
Endometritis.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 10 Endometritis
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 18/637 16/552 12.6 % 0.97 [ 0.50, 1.89 ]
East 2006 4/305 1/295 0.7 % 3.87 [ 0.43, 34.41 ]
Subtotal (95% CI) 942 847 13.3 % 1.14 [ 0.61, 2.12 ]
Total events: 22 (FPO + CTG), 17 (CTG only)
Heterogeneity: Chi2 = 1.41, df = 1 (P = 0.23); I2 =29%
Test for overall effect: Z = 0.40 (P = 0.69)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 114/2629 120/2712 86.7 % 0.98 [ 0.76, 1.26 ]
Subtotal (95% CI) 2629 2712 86.7 % 0.98 [ 0.76, 1.26 ]
Total events: 114 (FPO + CTG), 120 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.87)
Total (95% CI) 3644 3632 100.0 % 1.00 [ 0.79, 1.26 ]
Total events: 136 (FPO + CTG), 137 (CTG only)
Heterogeneity: Chi2 = 1.50, df = 2 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Chi2 = 0.19, df = 1 (P = 0.66), I2 =0.0%
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Analysis 2.11. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 11
Uterine rupture.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 11 Uterine rupture
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 2/637 2/552 100.0 % 0.87 [ 0.12, 6.13 ]
East 2006 0/305 0/295 Not estimable
Subtotal (95% CI) 942 847 100.0 % 0.87 [ 0.12, 6.13 ]
Total events: 2 (FPO + CTG), 2 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.14 (P = 0.89)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 2.12. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 12
Length of hospital stay (days).
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 12 Length of hospital stay (days)
Study or subgroup FPO + CTG CTG only
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 305 4.4 (1.86) 295 4.46 (1.85) 100.0 % -0.06 [ -0.36, 0.24 ]
Subtotal (95% CI) 305 295 100.0 % -0.06 [ -0.36, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 73 4 (2) 73 4 (2) 100.0 % 0.0 [ -0.65, 0.65 ]
Subtotal (95% CI) 73 73 100.0 % 0.0 [ -0.65, 0.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
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Analysis 2.13. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 13
Satisfaction with labour.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 13 Satisfaction with labour
Study or subgroup FPO + CTG CTG only
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 233 9.3 (1.91) 215 9.1 (1.99) 100.0 % 0.20 [ -0.16, 0.56 ]
Subtotal (95% CI) 233 215 100.0 % 0.20 [ -0.16, 0.56 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
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Analysis 2.14. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 14
Satisfaction with fetal monitoring in labour.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 14 Satisfaction with fetal monitoring in labour
Study or subgroup FPO + CTG CTG only
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 233 12.6 (2.38) 215 12.2 (2.43) 100.0 % 0.40 [ -0.05, 0.85 ]
Subtotal (95% CI) 233 215 100.0 % 0.40 [ -0.05, 0.85 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.76 (P = 0.079)
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Analysis 2.15. Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 15
Death.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 2 Secondary outcomes: maternal: FPO + CTG versus CTG only
Outcome: 15 Death
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 0/637 0/552 Not estimable
East 2006 0/305 0/295 Not estimable
Subtotal (95% CI) 942 847 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 3.1. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 1
Apgar score less than 4 at 5 minutes.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 1 Apgar score less than 4 at 5 minutes
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 1/637 0/552 100.0 % 2.60 [ 0.11, 63.70 ]
East 2006 0/305 0/295 Not estimable
Subtotal (95% CI) 942 847 100.0 % 2.60 [ 0.11, 63.70 ]
Total events: 1 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 6/2629 3/2712 100.0 % 2.06 [ 0.52, 8.24 ]
Subtotal (95% CI) 2629 2712 100.0 % 2.06 [ 0.52, 8.24 ]
Total events: 6 (FPO + CTG), 3 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
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Analysis 3.2. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 2
Apgar score less than 7 at 5 minutes.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 2 Apgar score less than 7 at 5 minutes
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 34 weeks, FBS not required prior to study entry
Garite 2000 14/637 19/552 71.6 % 0.64 [ 0.32, 1.26 ]
East 2006 5/305 6/295 21.4 % 0.81 [ 0.25, 2.61 ]
Caliskan 2009 1/114 2/116 7.0 % 0.51 [ 0.05, 5.53 ]
Subtotal (95% CI) 1056 963 100.0 % 0.67 [ 0.38, 1.18 ]
Total events: 20 (FPO + CTG), 27 (CTG only)
Heterogeneity: Chi2 = 0.16, df = 2 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 1.40 (P = 0.16)
2 Gestation from 36 weeks, FBS required prior to study entry
Kuhnert 2004 1/73 0/73 100.0 % 3.00 [ 0.12, 72.45 ]
Subtotal (95% CI) 73 73 100.0 % 3.00 [ 0.12, 72.45 ]
Total events: 1 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
3 Gestation from 28 weeks, FBS not required prior to study entry
Klauser 2005 3/150 5/177 100.0 % 0.71 [ 0.17, 2.91 ]
Subtotal (95% CI) 150 177 100.0 % 0.71 [ 0.17, 2.91 ]
Total events: 3 (FPO + CTG), 5 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
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Analysis 3.3. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 3
Length of hospital stay (days).
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 3 Length of hospital stay (days)
Study or subgroup FPO + CTG CTG only
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 305 3.74 (2.35) 295 3.74 (1.74) 100.0 % 0.0 [ -0.33, 0.33 ]
Subtotal (95% CI) 305 295 100.0 % 0.0 [ -0.33, 0.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 73 2 (1) 73 2 (1) 100.0 % 0.0 [ -0.32, 0.32 ]
Subtotal (95% CI) 73 73 100.0 % 0.0 [ -0.32, 0.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
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Analysis 3.4. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 4
Umbilical arterial pH less than 7.10.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 4 Umbilical arterial pH less than 7.10
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 32/637 27/552 70.1 % 1.03 [ 0.62, 1.69 ]
East 2006 13/272 12/240 29.9 % 0.96 [ 0.44, 2.05 ]
Subtotal (95% CI) 909 792 100.0 % 1.01 [ 0.66, 1.53 ]
Total events: 45 (FPO + CTG), 39 (CTG only)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.98)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 1/73 6/73 100.0 % 0.17 [ 0.02, 1.35 ]
Subtotal (95% CI) 73 73 100.0 % 0.17 [ 0.02, 1.35 ]
Total events: 1 (FPO + CTG), 6 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.093)
3 Gestation from 28 weeks, FBS not required prior to study entry
Klauser 2005 5/150 13/177 100.0 % 0.45 [ 0.17, 1.24 ]
Subtotal (95% CI) 150 177 100.0 % 0.45 [ 0.17, 1.24 ]
Total events: 5 (FPO + CTG), 13 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
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Analysis 3.5. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 5
Umbilical arterial base excess less than -12.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 5 Umbilical arterial base excess less than -12
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 13/637 13/552 68.5 % 0.87 [ 0.41, 1.85 ]
East 2006 10/257 6/224 31.5 % 1.45 [ 0.54, 3.93 ]
Subtotal (95% CI) 894 776 100.0 % 1.05 [ 0.58, 1.92 ]
Total events: 23 (FPO + CTG), 19 (CTG only)
Heterogeneity: Chi2 = 0.65, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.16 (P = 0.87)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 2/73 2/73 100.0 % 1.00 [ 0.14, 6.91 ]
Subtotal (95% CI) 73 73 100.0 % 1.00 [ 0.14, 6.91 ]
Total events: 2 (FPO + CTG), 2 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
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Analysis 3.6. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 6
Admission to neonatal intensive care unit.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 6 Admission to neonatal intensive care unit
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 34 weeks, FBS not required prior to study entry
Garite 2000 104/637 79/552 83.2 % 1.14 [ 0.87, 1.49 ]
East 2006 9/305 11/295 11.0 % 0.79 [ 0.33, 1.88 ]
Caliskan 2009 5/114 6/116 5.8 % 0.85 [ 0.27, 2.70 ]
Subtotal (95% CI) 1056 963 100.0 % 1.09 [ 0.84, 1.39 ]
Total events: 118 (FPO + CTG), 96 (CTG only)
Heterogeneity: Chi2 = 0.82, df = 2 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.52)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 5/73 5/73 100.0 % 1.00 [ 0.30, 3.31 ]
Subtotal (95% CI) 73 73 100.0 % 1.00 [ 0.30, 3.31 ]
Total events: 5 (FPO + CTG), 5 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
3 Gestation from 28 weeks, FBS not required prior to study entry
Klauser 2005 20/150 25/177 100.0 % 0.94 [ 0.55, 1.63 ]
Subtotal (95% CI) 150 177 100.0 % 0.94 [ 0.55, 1.63 ]
Total events: 20 (FPO + CTG), 25 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.84)
4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 126/2629 147/2712 100.0 % 0.88 [ 0.70, 1.11 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.88 [ 0.70, 1.11 ]
Total events: 126 (FPO + CTG), 147 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
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Analysis 3.7. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 7
Death.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 7 Death
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 3/637 2/552 58.4 % 1.30 [ 0.22, 7.75 ]
East 2006 0/305 1/295 41.6 % 0.32 [ 0.01, 7.88 ]
Subtotal (95% CI) 942 847 100.0 % 0.89 [ 0.20, 3.97 ]
Total events: 3 (FPO + CTG), 3 (CTG only)
Heterogeneity: Chi2 = 0.56, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.15 (P = 0.88)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 0/2629 1/2712 100.0 % 0.34 [ 0.01, 8.44 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.34 [ 0.01, 8.44 ]
Total events: 0 (FPO + CTG), 1 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.51)
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Analysis 3.8. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 8
Death, hypoxic-ischaemic encephalopathy, or both.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 8 Death, hypoxic-ischaemic encephalopathy, or both
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 3/637 2/552 76.2 % 1.30 [ 0.22, 7.75 ]
East 2006 0/305 1/295 23.8 % 0.32 [ 0.01, 7.88 ]
Subtotal (95% CI) 942 847 100.0 % 0.93 [ 0.20, 4.44 ]
Total events: 3 (FPO + CTG), 3 (CTG only)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.56, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
2 Gestation from 36 weeks, FBS required prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry
Bloom 2006 0/2629 2/2712 100.0 % 0.21 [ 0.01, 4.30 ]
Subtotal (95% CI) 2629 2712 100.0 % 0.21 [ 0.01, 4.30 ]
Total events: 0 (FPO + CTG), 2 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
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Analysis 3.9. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 9
Death, seizures, or both.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 9 Death, seizures, or both
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 3/637 3/552 75.0 % 0.87 [ 0.18, 4.28 ]
East 2006 1/305 1/295 25.0 % 0.97 [ 0.06, 15.39 ]
Subtotal (95% CI) 942 847 100.0 % 0.89 [ 0.22, 3.55 ]
Total events: 4 (FPO + CTG), 4 (CTG only)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.16 (P = 0.87)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 3.10. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome
10 Death, long-term neurodevelopmental problem, or both.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 10 Death, long-term neurodevelopmental problem, or both
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
Garite 2000 3/637 2/552 76.2 % 1.30 [ 0.22, 7.75 ]
East 2006 0/305 1/295 23.8 % 0.32 [ 0.01, 7.88 ]
Subtotal (95% CI) 942 847 100.0 % 0.93 [ 0.20, 4.44 ]
Total events: 3 (FPO + CTG), 3 (CTG only)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.56, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
0.01 0.1 1 10 100
Favours FPO + CTG Favours CTG only
64Fetal pulse oximetry for fetal assessment in labour (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.11. Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome
11 Skin trauma.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only
Outcome: 11 Skin trauma
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gestation from 36 weeks, FBS not required prior to study entry
East 2006 3/305 4/295 100.0 % 0.73 [ 0.16, 3.21 ]
Subtotal (95% CI) 305 295 100.0 % 0.73 [ 0.16, 3.21 ]
Total events: 3 (FPO + CTG), 4 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
2 Gestation from 36 weeks, FBS prior to study entry
Kuhnert 2004 0/73 0/73 Not estimable
Subtotal (95% CI) 73 73 Not estimable
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 4.1. Comparison 4 Subgroup: fetal blood sampling: primary outcomes, Outcome 1 Caesarean
section.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 4 Subgroup: fetal blood sampling: primary outcomes
Outcome: 1 Caesarean section
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
East 2006 27/41 84/157 1.23 [ 0.94, 1.60 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 27 (FPO + CTG), 84 (CTG only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
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Analysis 4.2. Comparison 4 Subgroup: fetal blood sampling: primary outcomes, Outcome 2 Neonatal
seizures.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 4 Subgroup: fetal blood sampling: primary outcomes
Outcome: 2 Neonatal seizures
Study or subgroup FPO + CTG CTG only Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
East 2006 0/41 0/157 Not estimable
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (FPO + CTG), 0 (CTG only)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 5.1. Comparison 5 Primary outcomes: FPO + CTG versus fetal ECG + CTG, Outcome 1
Caesarean section.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 5 Primary outcomes: FPO + CTG versus fetal ECG + CTG
Outcome: 1 Caesarean section
Study or subgroup FPO + CTG Fetal ECG + CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Valverde 2011 42/90 27/90 100.0 % 1.56 [ 1.06, 2.29 ]
Total (95% CI) 90 90 100.0 % 1.56 [ 1.06, 2.29 ]
Total events: 42 (FPO + CTG), 27 (Fetal ECG + CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.25 (P = 0.025)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours FPO + CTG Favours fetal ECG + CTG
Analysis 6.1. Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG,
Outcome 1 Caesarean section for nonreassuring fetal status.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG
Outcome: 1 Caesarean section for nonreassuring fetal status
Study or subgroup FPO + CTG fetal ECG + CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Valverde 2011 29/90 17/90 100.0 % 1.71 [ 1.01, 2.88 ]
Total (95% CI) 90 90 100.0 % 1.71 [ 1.01, 2.88 ]
Total events: 29 (FPO + CTG), 17 (fetal ECG + CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.045)
Test for subgroup differences: Not applicable
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Analysis 6.2. Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG,
Outcome 2 Caesarean section for dystocia.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG
Outcome: 2 Caesarean section for dystocia
Study or subgroup FPO + CTG fetal ECG + CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Valverde 2011 13/90 10/90 100.0 % 1.30 [ 0.60, 2.81 ]
Total (95% CI) 90 90 100.0 % 1.30 [ 0.60, 2.81 ]
Total events: 13 (FPO + CTG), 10 (fetal ECG + CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours FPO + CTG Favours fetal ECG + CTG
Analysis 6.3. Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG,
Outcome 3 Operative birth (caesarean section, forceps, vacuum).
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG
Outcome: 3 Operative birth (caesarean section, forceps, vacuum)
Study or subgroup FPO + CTG fetal ECG + CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Valverde 2011 71/90 59/90 100.0 % 1.20 [ 1.00, 1.45 ]
Total (95% CI) 90 90 100.0 % 1.20 [ 1.00, 1.45 ]
Total events: 71 (FPO + CTG), 59 (fetal ECG + CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.97 (P = 0.049)
Test for subgroup differences: Not applicable
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Analysis 6.4. Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG,
Outcome 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG
Outcome: 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status
Study or subgroup FPO + CTG fetal ECG + CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Valverde 2011 44/90 36/90 100.0 % 1.22 [ 0.88, 1.70 ]
Total (95% CI) 90 90 100.0 % 1.22 [ 0.88, 1.70 ]
Total events: 44 (FPO + CTG), 36 (fetal ECG + CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.19 (P = 0.23)
Test for subgroup differences: Not applicable
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Analysis 7.1. Comparison 7 Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG,
Outcome 1 Admission to neonatal intensive care unit.
Review: Fetal pulse oximetry for fetal assessment in labour
Comparison: 7 Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG
Outcome: 1 Admission to neonatal intensive care unit
Study or subgroup FPO + CTG fetal ECG + CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Valverde 2011 1/90 1/90 100.0 % 1.00 [ 0.06, 15.74 ]
Total (95% CI) 90 90 100.0 % 1.00 [ 0.06, 15.74 ]
Total events: 1 (FPO + CTG), 1 (fetal ECG + CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. Search strategies
Authors searchedMEDLINE (1994 toMay 2010), EMBASE (1994 toMay 2010) and Current Contents (1994 toMay 2010): searches
were conducted from 1994 onwards as pulse oximetry technology calibrated for the fetal environment has only been available since
1994. Searches were conducted using search terms: (labour OR labor OR intrapartum) AND (oximetry OR pulse oximetry OR oxygen
saturation) AND (clinical trial phase 1 OR clinical trial phase II OR clinical trial phase III OR controlled clinical trial OR randomized
controlled trial OR randomised controlled trial) AND (fetal distress OR fetal heart OR fetal monitoring OR nonreassuring OR non-
reassuring).
F E E D B A C K
Thornton, July 2006
Summary
The abstract states ’Use of fetal pulse oximetry with CTG decreased operative delivery (caesarean section, forceps, vacuum) for
nonreassuring fetal status (RR 0.71, 95% CI 0.55 to 0.93) compared with CTG alone.’
The results text also states ’There was a statistically significant decrease in operative delivery (caesarean section, forceps or vacuum birth)
for nonreassuring fetal status (RR 0.71, 95% CI 0.55 to 0.93).
But the results tables show a Relative Risk (Fixed) 95% CI 1.07 [0.95, 1.21]. Am I missing something, or has there been a mistake?
(Summary of comment from Jim Thornton, July 2006)
Reply
The data in the text are correct. The data quoted from the results table refer to the outcome ’operative delivery (caesarean section,
forceps or vacuum birth)’, which is for all indications; the data quoted in the text are for ’operative delivery (caesarean section, forceps
or vacuum birth) for nonreassuring fetal status’ and are correct.
To help clarify this, the outcome in the review now includes the wording ’for all indications’.
(Summary of response from Christine East, November 2006)
Contributors
Feedback: Jim Thornton
Reply: Christine East
WH A T ’ S N E W
Last assessed as up-to-date: 31 May 2014.
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Date Event Description
31 May 2014 New citation required but conclusions have not changed The addition of the trial to this updated review did not
change the conclusions
31 May 2014 New search has been performed Search updated and one additional trial included in the
review (Valverde 2011). Methods and literature review
updated.
H I S T O R Y
Protocol first published: Issue 1, 2003
Review first published: Issue 4, 2004
Date Event Description
11 September 2012 Amended Contact details updated.
31 May 2010 New search has been performed One new trial added to the review. This did not change
the conclusions of the review. Prof FY Chan removed
from authorship (deceased 2007) although previous
input gratefully recognised
1 October 2009 Amended Search updated. Five reports added to Studies await-
ing classification (Caliskan 2009a; East 2006b; Prieto
2008a; Rouse 2008; Rouse 2009)
10 November 2008 Amended Contact details updated.
18 February 2008 Amended Converted to new review format.
17 January 2007 New citation required and conclusions have changed Search updated in November 2006. We identified and
included four new trials (Bloom 2006; East 2006;
Klauser 2005; Kuhnert 2004).
The original version of this review concluded that the
addition of fetal pulse oximetry to cardiotocography
decreased the caesarean section and operative delivery
rates for nonreassuring fetal status, with no difference
in overall caesarean section rates. The addition of the
four new trials confirmed these conclusionswhen non-
reassuring fetal status was identified prior to study en-
try. When nonreassuring fetal status was not present
prior to study entry, knowledge of fetal pulse oximetry
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(Continued)
values made no difference to caesarean section rates
for nonreassuring fetal status or for all indications
C O N T R I B U T I O N S O F A U T H O R S
C East compiled the protocol and original review with input from all co-authors. L Begg joined the authorship in 2006 for the 2007
update. FY Chan died in 2007. R Lau joined the authorship for the 2014 update.
C East, FY Chan (to 2007), P Colditz, R Lau and/or L Begg reviewed the articles for consideration of inclusion/exclusion and abstracted
data for the 2007 review. In particular, L Begg, who was not a co-investigator on the trial by the other three authors, reviewed that trial
for quality and suitability for inclusion in this review.
C East and R Lau updated this review in 2014, with input from the remaining authors (PC, LB).
D E C L A R A T I O N S O F I N T E R E S T
Three authors (C East, FY Chan, P Colditz) were chief investigators in the Australian multicentre randomised controlled trial of fetal
intrapartum pulse oximetry (East 2006). That trial was supported in part by a research grant and equipment loan from Nellcor Inc,
manufacturers of a fetal pulse oximetry system. An additional co-author who was not an investigator in that trial, L Begg, joined the
review team to evaluate that trial for incorporation in the 2007 update of the review.
S O U R C E S O F S U P P O R T
Internal sources
• Perinatal Research Centre, The University of Queensland, Royal Brisbane and Women’s Hospital, Herston, Queensland,
Australia.
• Department of Obstetrics and Gynaecology, University of Melbourne, Australia.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The 2010 and 2014 updates have incorporated the current standard methods used by the Pregnancy and Childbirth Group at the time,
which have been modified since the original protocol was published (East 2003). In the 2014 update, the use of additional searching
was discontinued, as the comprehensive search through the Cochrane Pregnancy and Childbirth Group has identified every publication
used in the successive updates of this review, with no additional studies identified in the additional searches.
For the planned subgroup analyses, we added lactate measurement as a parameter for fetal scalp blood sampling (following randomi-
sation), given that this is often used instead of blood gas analysis in contemporary clinical practice.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Cardiotocography; Cesarean Section; Delivery,Obstetric [statistics & numerical data]; FetalMonitoring [∗methods];Oximetry [adverse
effects; ∗methods]
MeSH check words
Female; Humans; Pregnancy
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